This database of osmoregulated proteins in mammalian cells is based on previously published high-throughput and hypothesis-driven data sets from the NIH NHLBI Systems Biology Center and other studies available in the literature.The database was created by Cameron R. Grady, Joan D. Ferraris, Maurice B. Burg, and Mark A. Knepper. Hypertonicity includes elevation of extracellular tonicity by the addition of inorganic ions such as NaCl or organic solutes such as sorbitol or raffinose. Email to: knepperm@nhlbi.nih.gov.
The data in the first five columns can be read as a sentence by either humans or computers. Additional columns contain ancillary information that can be viewed as a continuation of the sentence. This structure is used to facilitate computational network building. Click Here for Terminology
Database is hosted by the Epithelial Systems Biology Laboratory, National Heart, Lung and Blood Institute (Intramural Research Program, NIH). Please cite: Grady CG, Knepper MA, Burg MB, and Ferraris JD. Database of osmoregulated proteins in mammalian cells. Physiol Rep. 2014 PMID: 25355853. ... Database updated: May 22th, 2015 (download data)
Subject | Verb Phrase (Action) | Object (Gene Symbol) | Phosphosite (if any) | Cell Type | Protein Description | Reference |
---|---|---|---|---|---|---|
Hypertonicity | decreases activity of | HDAC3 | in 3T3 | histone deacetylase 3 | Xia 2007 | |
Hypertonicity | decreases mRNA abundance of | JUN | in 3T3 | jun proto-oncogene | Xia 2007 | |
Hypertonicity | increases activity of | DYT10 | in 3T3 | dystonia 10 | Zhuang 2000 | |
Hypertonicity | increases activity of | MAP3K1 | in 3T3 | mitogen-activated protein kinase kinase kinase 1 | Lu 2004 | |
Hypertonicity | increases activity of | NFAT5 | in 3T3 | nuclear factor of activated T-cells 5, tonicity-responsive | Hansen 2012 | |
Hypertonicity | increases activity of | NFAT5 | in 3T3 | nuclear factor of activated T-cells 5, tonicity-responsive | Ko 2002 | |
Hypertonicity | increases activity of | PKN1 | in 3T3 | protein kinase N1 | Torbett 2003 | |
Hypertonicity | increases mRNA abundance of | PTK2 | in 3T3 | protein tyrosine kinase 2 | Lunn 2004 | |
Hypertonicity | increases mRNA abundance of | SLC6A6 | in 3T3 | solute carrier family 6 (neurotransmitter transporter), member 6 | Hansen 2012 | |
Hypertonicity | increases phosphorylation of | BCAR1 | in 3T3 | breast cancer anti-estrogen resistance 1 | Lunn 2004 | |
Hypertonicity | increases phosphorylation of | CAV1 | at Y14 | in 3T3 | caveolin 1, caveolae protein, 22kDa | Volonte 2001 |
Hypertonicity | increases phosphorylation of | HNRNPA1 | in 3T3 | heterogeneous nuclear ribonucleoprotein A1 | Allemand 2005 | |
Hypertonicity | increases phosphorylation of | MAP3K1 | in 3T3 | mitogen-activated protein kinase kinase kinase 1 | Lu 2004 | |
Hypertonicity | increases phosphorylation of | PXN | in 3T3 | paxillin | Lunn 2004 | |
Hypertonicity | increases phosphorylation of | PRKD1 | at S744,S748, and S916 | in 3T3 | protein kinase D1 | Lim 2008 |
Hypertonicity | increases phosphorylation of | PKN1 | in 3T3 | protein kinase N1 | Torbett 2003 | |
Hypertonicity | increases phosphorylation of | PTK2 | at Y397 and Y577 | in 3T3 | protein tyrosine kinase 2 | Lunn 2004 |
Hypertonicity | increases translocation of | DYT10 | in 3T3 | dystonia 10 | Zhuang 2000 | |
Hypertonicity | increases translocation of | HNRNPA1 | in 3T3 | heterogeneous nuclear ribonucleoprotein A1 | Allemand 2005 | |
Hypertonicity | increases translocation of | PRKCA | in 3T3 | protein kinase C, alpha | Zhuang 2000 | |
Hypertonicity | increases translocation of | PRKCD | in 3T3 | protein kinase C, delta | Zhuang 2000 | |
Hypertonicity | increases translocation of | PRKCE | in 3T3 | protein kinase C, epsilon | Zhuang 2000 | |
Hypertonicity | increases translocation of | PKN1 | in 3T3 | protein kinase N1 | Torbett 2003 | |
Hypertonicity | increases translocation of | PTK2 | in 3T3 | protein tyrosine kinase 2 | Lunn 2004 | |
Hypertonicity | increases translocation of | PDK1 | in 3T3 | pyruvate dehydrogenase kinase, isozyme 1 | Torbett 2003 | |
Hypertonicity | increases translocation of | RAC1 | in 3T3 | v-akt murine thymoma viral oncogene homolog 1 | Torbett 2003 | |
Hypertonicity | increases activity of | CDC42 | in 3T3-L1 | cell division cycle 42 | Roig 2000 | |
Hypertonicity | increases activity of | PAK2 | in 3T3-L1 | p21 protein (Cdc42/Rac)-activated kinase 2 | Roig 2000 | |
Hypertonicity | increases binding of | GAB1 | in 3T3-L1 | GRB2-associated binding protein 1 | Gual 2002 | |
Hypertonicity | increases binding of | GAB1 | in 3T3-L1 | GRB2-associated binding protein 1 | Janez 2000 | |
Hypertonicity | increases binding of | PAK2 | in 3T3-L1 | p21 protein (Cdc42/Rac)-activated kinase 2 | Roig 2000 | |
Hypertonicity | increases binding of | PIK3CA | in 3T3-L1 | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | Janez 2000 | |
Hypertonicity | increases binding of | CRK | in 3T3-L1 | v-crk avian sarcoma virus CT10 oncogene homolog | Gual 2002 | |
Hypertonicity | increases phosphorylation of | BCAR1 | in 3T3-L1 | breast cancer anti-estrogen resistance 1 | Chen 1997 | |
Hypertonicity | increases phosphorylation of | CBL | in 3T3-L1 | Cbl proto-oncogene, E3 ubiquitin protein ligase | Chen 1997 | |
Hypertonicity | increases phosphorylation of | GAB1 | in 3T3-L1 | GRB2-associated binding protein 1 | Gual 2002 | |
Hypertonicity | increases phosphorylation of | GAB1 | in 3T3-L1 | GRB2-associated binding protein 1 | Janez 2000 | |
Hypertonicity | increases phosphorylation of | IRS1 | at S307 | in 3T3-L1 | insulin receptor substrate 1 | Gual 2003 |
Hypertonicity | increases phosphorylation of | PIK3CA | in 3T3-L1 | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | Janez 2000 | |
Hypertonicity | increases phosphorylation of | PLCG1 | in 3T3-L1 | phospholipase C, gamma 1 | Gual 2002 | |
Hypertonicity | increases phosphorylation of | PTK2B | in 3T3-L1 | protein tyrosine kinase 2 beta | Chen 1997 | |
Hypertonicity | increases translocation of | CDC42 | in 3T3-L1 | cell division cycle 42 | Roig 2000 | |
Hypertonicity | increases translocation of | PAK2 | in 3T3-L1 | p21 protein (Cdc42/Rac)-activated kinase 2 | Roig 2000 | |
Hypertonicity | increases translocation of | SLC2A4 | in 3T3-L1 | solute carrier family 2 (facilitated glucose transporter), member 4 | Janez 2000 | |
Hypertonicity | decreases mRNA abundance of | JUN | in 3Y1 | jun proto-oncogene | Xia 2007 | |
Hypertonicity | decreases protein abundance of | HDAC3 | in 3Y1 | histone deacetylase 3 | Xia 2007 | |
Hypertonicity | decreases protein abundance of | JUN | in 3Y1 | jun proto-oncogene | Xia 2007 | |
Hypertonicity | decreases protein abundance of | JUN | in 3Y1 | jun proto-oncogene | Xia 2007 | |
Hypertonicity | increases activity of | MAPK1 | in 3Y1 | mitogen-activated protein kinase 1 | Matsuda 1995 | |
Hypertonicity | increases activity of | MAPK3 | in 3Y1 | mitogen-activated protein kinase 3 | Matsuda 1995 | |
Hypertonicity | increases activity of | MAPK8 | in 3Y1 | mitogen-activated protein kinase 8 | Matsuda 1995 | |
Hypertonicity | increases activity of | MAPK9 | in 3Y1 | mitogen-activated protein kinase 9 | Matsuda 1995 | |
Hypertonicity | increases activity of | MAP2K1 | in 3Y1 | mitogen-activated protein kinase kinase 1 | Matsuda 1995 | |
Hypertonicity | increases activity of | MAP3K1 | in 3Y1 | mitogen-activated protein kinase kinase kinase 1 | Matsuda 1995 | |
Hypertonicity | increases activity of | RAF1 | in 3Y1 | v-raf-1 murine leukemia viral oncogene homolog 1 | Matsuda 1995 | |
Hypertonicity | increases phosphorylation of | JUN | at S63 | in 3Y1 | jun proto-oncogene | Xia 2007 |
Hypertonicity | increases activity of | HIF1A | in AEC | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Zhou 2007 | |
Hypertonicity | increases mRNA abundance of | AQP5 | in AEC | aquaporin 5 | Zhou 2007 | |
Hypertonicity | increases protein abundance of | AQP5 | in AEC | aquaporin 5 | Zhou 2007 | |
Hypertonicity | increases transcription of | AQP5 | in AEC | aquaporin 5 | Zhou 2007 | |
Hypertonicity | increases mRNA abundance of | CRYAB | in astrocytes | crystallin, alpha B | Head 1994 | |
Hypertonicity | increases protein abundance of | CRYAB | in astrocytes | crystallin, alpha B | Head 1994 | |
Hypertonicity | increases mRNA abundance of | ACAN | in ATDC5 | aggrecan | Caron 2013 | |
Hypertonicity | increases mRNA abundance of | COL2A1 | in ATDC5 | collagen, type II, alpha 1 | Caron 2013 | |
Hypertonicity | increases mRNA abundance of | COL10A1 | in ATDC5 | collagen, type X, alpha 1 | Caron 2013 | |
Hypertonicity | increases mRNA abundance of | RUNX2 | in ATDC5 | runt-related transcription factor 2 | Caron 2013 | |
Hypertonicity | increases mRNA abundance of | SOX9 | in ATDC5 | SRY (sex determining region Y)-box 9 | Caron 2013 | |
Hypertonicity | increases protein abundance of | COL2A1 | in ATDC5 | collagen, type II, alpha 1 | Caron 2013 | |
Hypertonicity | decreases activity of | NKX2-1 | in B35 | NK2 homeobox 1 | Kim 2008 | |
Hypertonicity | decreases mRNA abundance of | NKX2-1 | in B35 | NK2 homeobox 1 | Kim 2008 | |
Hypertonicity | decreases protein abundance of | NKX2-1 | in B35 | NK2 homeobox 1 | Kim 2008 | |
Hypertonicity | decreases transcription of | NKX2-1 | in B35 | NK2 homeobox 1 | Kim 2008 | |
Hypertonicity | increases protein abundance of | IL8 | in BEAS-2B | interleukin 8 | Chan 2006 | |
Hypertonicity | increases transcription of | IL8 | in BEAS-2B | interleukin 8 | Chan 2006 | |
Hypertonicity | increases mRNA abundance of | ATF3 | in brain | activating transcription factor 3 | Maallem 2008 | |
Hypertonicity | increases mRNA abundance of | APOLD1 | in brain | apolipoprotein L domain containing 1 | Maallem 2008 | |
Hypertonicity | increases mRNA abundance of | BTG2 | in brain | BTG family, member 2 | Maallem 2008 | |
Hypertonicity | increases mRNA abundance of | CCL3 | in brain | chemokine (C-C motif) ligand 3 | Maallem 2008 | |
Hypertonicity | increases mRNA abundance of | CYR61 | in brain | cysteine-rich, angiogenic inducer, 61 | Maallem 2008 | |
Hypertonicity | increases mRNA abundance of | DUSP1 | in brain | dual specificity phosphatase 1 | Maallem 2008 | |
Hypertonicity | increases mRNA abundance of | FOS | in brain | FBJ murine osteosarcoma viral oncogene homolog | Maallem 2008 | |
Hypertonicity | increases mRNA abundance of | JUND | in brain | jun D proto-oncogene | Maallem 2008 | |
Hypertonicity | increases mRNA abundance of | KLF4 | in brain | Kruppel-like factor 4 (gut) | Maallem 2008 | |
Hypertonicity | increases mRNA abundance of | NFKB1 | in brain | nuclear factor related to kappaB binding protein | Maallem 2008 | |
Hypertonicity | increases mRNA abundance of | SLC38A2 | in brain | solute carrier family 38, member 2 | Maallem 2008 | |
Hypertonicity | increases mRNA abundance of | ZFP36 | in brain | ZFP36 ring finger protein | Maallem 2008 | |
Hypertonicity | increases mRNA abundance of | CYP3A4 | in C2bbel | cytochrome P450, family 3, subfamily A, polypeptide 4 | Kosuge 2007 | |
Hypertonicity | increases protein abundance of | CYP3A4 | in C2bbel | cytochrome P450, family 3, subfamily A, polypeptide 4 | Kosuge 2007 | |
Hypertonicity | increases mRNA abundance of | IL6 | in Caco-2 | interleukin 6 | Hubert 2004 | |
Hypertonicity | increases protein abundance of | IL6 | in Caco-2 | interleukin 6 | Hubert 2004 | |
Hypertonicity | increases protein abundance of | IL8 | in Caco-2 | interleukin 8 | Hubert 2004 | |
Hypertonicity | increases translocation of | CCM2 | in Caco-2 | cerebral cavernous malformation 2 | Wu 2013 | |
Hypertonicity | increases activity of | NFAT5 | in cardiomyocytes | nuclear factor of activated T-cells 5, tonicity-responsive | Navarro 2008 | |
Hypertonicity | increases mRNA abundance of | NFAT5 | in cardiomyocytes | nuclear factor of activated T-cells 5, tonicity-responsive | Navarro 2008 | |
Hypertonicity | increases protein abundance of | NFAT5 | in cardiomyocytes | nuclear factor of activated T-cells 5, tonicity-responsive | Navarro 2008 | |
Hypertonicity | decreases activity of | SRC | in CHO | v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog | Kapus 1999 | |
Hypertonicity | increases activity of | CDC42 | in CHO | cell division cycle 42 | Di Ciano 2002 | |
Hypertonicity | increases activity of | FER | in CHO | fer (fps/fes related) tyrosine kinase | Kapus 2000 | |
Hypertonicity | increases activity of | FYN | in CHO | FYN oncogene related to SRC, FGR, YES | Kapus 1999 | |
Hypertonicity | increases activity of | RAC1 | in CHO | v-akt murine thymoma viral oncogene homolog 1 | Di Ciano 2002 | |
Hypertonicity | increases phosphorylation of | CTNNA1 | at T421 | in CHO | catenin (cadherin-associated protein), alpha 1, 102kDa | Kapus 2000 |
Hypertonicity | increases phosphorylation of | CTNNA1 | at T466 | in CHO | catenin (cadherin-associated protein), alpha 1, 102kDa | Kapus 2000 |
Hypertonicity | increases phosphorylation of | CTNNA1 | at T482 | in CHO | catenin (cadherin-associated protein), alpha 1, 102kDa | Kapus 2000 |
Hypertonicity | increases phosphorylation of | CTNNB1 | at T421 | in CHO | catenin (cadherin-associated protein), beta 1, 88kDa | Kapus 2000 |
Hypertonicity | increases phosphorylation of | CTNNB1 | at T466 | in CHO | catenin (cadherin-associated protein), beta 1, 88kDa | Kapus 2000 |
Hypertonicity | increases phosphorylation of | CTNNB1 | at T482 | in CHO | catenin (cadherin-associated protein), beta 1, 88kDa | Kapus 2000 |
Hypertonicity | increases phosphorylation of | CTTND1 | in CHO | catenin (cadherin-associated protein), delta 1 | Kapus 2000 | |
Hypertonicity | increases phosphorylation of | CTTN | in CHO | cortactin | Kapus 1999 | |
Hypertonicity | increases phosphorylation of | FER | in CHO | fer (fps/fes related) tyrosine kinase | Kapus 2000 | |
Hypertonicity | increases phosphorylation of | IRS1 | in CHO | insulin receptor substrate 1 | Ouwens 2001 | |
Hypertonicity | increases phosphorylation of | SHC1 | in CHO | SHC (Src homology 2 domain containing) transforming protein 1 | Ouwens 2001 | |
Hypertonicity | increases translocation of | ACTG1 | in CHO | actin, gamma 1 | Di Ciano 2002 | |
Hypertonicity | increases translocation of | ACTR3 | in CHO | ARP3 actin-related protein 3 homolog (yeast) | Di Ciano 2002 | |
Hypertonicity | increases translocation of | CDC42 | in CHO | cell division cycle 42 | Di Ciano 2002 | |
Hypertonicity | increases translocation of | CTTN | in CHO | cortactin | Kapus 1999 | |
Hypertonicity | increases translocation of | RAC1 | in CHO | v-akt murine thymoma viral oncogene homolog 1 | Di Ciano 2002 | |
Hypertonicity | increases activity of | STAT3 | in CHO-K1 | signal transducer and activator of transcription 3 (acute-phase response factor) | Garnovskaya 2003 | |
Hypertonicity | increases binding of | CALM1 | in CHO-K1 | calmodulin 1 (phosphorylase kinase, delta) | Garnovskaya 2003 | |
Hypertonicity | increases binding of | JAK2 | in CHO-K1 | Janus kinase 2 | Garnovskaya 2003 | |
Hypertonicity | increases phosphorylation of | CALM1 | in CHO-K1 | calmodulin 1 (phosphorylase kinase, delta) | Garnovskaya 2003 | |
Hypertonicity | increases phosphorylation of | JAK2 | in CHO-K1 | Janus kinase 2 | Garnovskaya 2003 | |
Hypertonicity | increases phosphorylation of | STAT3 | in CHO-K1 | signal transducer and activator of transcription 3 (acute-phase response factor) | Garnovskaya 2003 | |
Hypertonicity | decreases mRNA abundance of | COL2A1 | in chondrocytes | collagen, type II, alpha 1 | Tew 2009 | |
Hypertonicity | decreases mRNA stability of | COL2A1 | in chondrocytes | collagen, type II, alpha 1 | Tew 2009 | |
Hypertonicity | decreases protein abundance of | COL1A1 | in chondrocytes | collagen, type II, alpha 1 | van der Windt 2010 | |
Hypertonicity | increases activity of | COL2A1 | in chondrocytes | collagen, type II, alpha 1 | Tew 2009 | |
Hypertonicity | increases mRNA abundance of | ACAN | in chondrocytes | aggrecan | van der Windt 2010 | |
Hypertonicity | increases mRNA abundance of | COL2A1 | in chondrocytes | collagen, type II, alpha 1 | van der Windt 2010 | |
Hypertonicity | increases mRNA abundance of | NFAT5 | in chondrocytes | nuclear factor of activated T-cells 5, tonicity-responsive | van der Windt 2010 | |
Hypertonicity | increases mRNA abundance of | S100A4 | in chondrocytes | S100 calcium binding protein A4 | van der Windt 2010 | |
Hypertonicity | increases mRNA abundance of | SLC6A12 | in chondrocytes | solute carrier family 6 (neurotransmitter transporter), member 12 | van der Windt 2010 | |
Hypertonicity | increases mRNA abundance of | SOX9 | in chondrocytes | SRY (sex determining region Y)-box 9 | Tew 2009 | |
Hypertonicity | increases mRNA abundance of | SOX9 | in chondrocytes | SRY (sex determining region Y)-box 9 | van der Windt 2010 | |
Hypertonicity | increases mRNA stability of | SOX9 | in chondrocytes | SRY (sex determining region Y)-box 9 | Tew 2009 | |
Hypertonicity | increases protein abundance of | COL2A1 | in chondrocytes | collagen, type II, alpha 1 | van der Windt 2010 | |
Hypertonicity | increases protein abundance of | SOX9 | in chondrocytes | SRY (sex determining region Y)-box 9 | Tew 2009 | |
Hypertonicity | increases activity of | SLC2A1 | in Clone 9 | solute carrier family 2 (facilitated glucose transporter), member 1 | Hwang 2001 | |
Hypertonicity | increases mRNA abundance of | SLC2A1 | in Clone 9 | solute carrier family 2 (facilitated glucose transporter), member 1 | Hwang 2001 | |
Hypertonicity | increases mRNA stability of | SLC2A1 | in Clone 9 | solute carrier family 2 (facilitated glucose transporter), member 1 | Hwang 2001 | |
Hypertonicity | increases protein abundance of | SLC2A1 | in Clone 9 | solute carrier family 2 (facilitated glucose transporter), member 1 | Hwang 2001 | |
Hypertonicity | increases transcription of | SLC2A1 | in Clone 9 | solute carrier family 2 (facilitated glucose transporter), member 1 | Hwang 2001 | |
Hypertonicity | increases activity of | NFAT5 | in colon cancer cells | nuclear factor of activated T-cells 5, tonicity-responsive | Chen 2011 | |
Hypertonicity | increases mRNA abundance of | S100A4 | in colon cancer cells | S100 calcium binding protein A4 | Chen 2011 | |
Hypertonicity | increases protein abundance of | NFAT5 | in colon cancer cells | nuclear factor of activated T-cells 5, tonicity-responsive | Chen 2011 | |
Hypertonicity | increases protein abundance of | S100A4 | in colon cancer cells | S100 calcium binding protein A4 | Chen 2011 | |
Hypertonicity | increases activity of | PAK2 | in COS7 | p21 protein (Cdc42/Rac)-activated kinase 2 | Miah 2004 | |
Hypertonicity | increases activity of | STAT1 | in COS7 | signal transducer and activator of transcription 1, 91kDa | Bode 1999 | |
Hypertonicity | increases activity of | STAT3 | in COS7 | signal transducer and activator of transcription 3 (acute-phase response factor) | Gatsios 1998 | |
Hypertonicity | increases activity of | SYK | in COS7 | spleen tyrosine kinase | Miah 2004 | |
Hypertonicity | increases activity of | AKT1 | in COS7 | v-akt murine thymoma viral oncogene homolog 1 | Konishi 1996 | |
Hypertonicity | increases binding of | PAK2 | in COS7 | p21 protein (Cdc42/Rac)-activated kinase 2 | Miah 2004 | |
Hypertonicity | increases binding of | STAT1 | in COS7 | signal transducer and activator of transcription 1, 91kDa | Gastios 1998 | |
Hypertonicity | increases binding of | STAT1 | in COS7 | signal transducer and activator of transcription 1, 91kDa | Gastios 1998 | |
Hypertonicity | increases binding of | STAT3 | in COS7 | signal transducer and activator of transcription 3 (acute-phase response factor) | Gastios 1998 | |
Hypertonicity | increases binding of | SYK | in COS7 | spleen tyrosine kinase | Miah 2004 | |
Hypertonicity | increases mRNA abundance of | TP73 | in COS7 | tumor protein p73 | Lin 2004 | |
Hypertonicity | increases phosphorylation of | JAK1 | in COS7 | Janus kinase 1 | Gastios 1998 | |
Hypertonicity | increases phosphorylation of | PTPN11 | in COS7 | protein tyrosine phosphatase, non-receptor type 11 | Bode 1999 | |
Hypertonicity | increases phosphorylation of | STAT1 | at Y701 | in COS7 | signal transducer and activator of transcription 1, 91kDa | Gastios 1998 |
Hypertonicity | increases phosphorylation of | STAT1 | in COS7 | signal transducer and activator of transcription 1, 91kDa | Bode 1999 | |
Hypertonicity | increases phosphorylation of | STAT3 | in COS7 | signal transducer and activator of transcription 3 (acute-phase response factor) | Gatsios 1998 | |
Hypertonicity | increases phosphorylation of | SYK | in COS7 | spleen tyrosine kinase | Miah 2004 | |
Hypertonicity | increases phosphorylation of | TYK2 | in COS7 | tyrosine kinase 2 | Gastios 1998 | |
Hypertonicity | increases phosphorylation of | TYK2 | in COS7 | tyrosine kinase 2 | Gastios 1998 | |
Hypertonicity | increases protein abundance of | TP73 | in COS7 | tumor protein p73 | Lin 2004 | |
Hypertonicity | increases translocation of | NFAT5 | in COS7 | nuclear factor of activated T-cells 5, tonicity-responsive | Zhang 2005 | |
Hypertonicity | increases translocation of | PAK2 | in COS7 | p21 protein (Cdc42/Rac)-activated kinase 2 | Miah 2004 | |
Hypertonicity | increases translocation of | STAT3 | in COS7 | signal transducer and activator of transcription 3 (acute-phase response factor) | Gatsios 1998 | |
Hypertonicity | increases translocation of | SYK | in COS7 | spleen tyrosine kinase | Miah 2004 | |
Hypertonicity | increases phosphorylation of | JAK1 | in Cos-7 | Janus kinase 1 | Bode 1999 | |
Hypertonicity | decreases activity of | RPS6KB1 | in CV1 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 | Parrott 1999 | |
Hypertonicity | decreases phosphorylation of | RPS6KB1 | in CV1 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 | Parrott 1999 | |
Hypertonicity | increases mRNA abundance of | BSND | in DCT | Bartter syndrome, infantile, with sensorineural deafness (Barttin) | Bergler 2008 | |
Hypertonicity | increases mRNA abundance of | CLCNKA | in DCT | chloride channel, voltage-sensitive Ka | Bergler 2008 | |
Hypertonicity | increases protein abundance of | BSND | in DCT | Bartter syndrome, infantile, with sensorineural deafness (Barttin) | Bergler 2008 | |
Hypertonicity | increases protein abundance of | CLCNKA | in DCT | chloride channel, voltage-sensitive Ka | Bergler 2008 | |
Hypertonicity | increases protein abundance of | MYL9 | in endothelial | myosin light chain 9 | Klein 1995 | |
Hypertonicity | increases activity of | EIF2AK1 | in erythroid | eukaryotic translation initiation factor 2-alpha kinase 1 | Lu 2001 | |
Hypertonicity | increases phosphorylation of | EIF2A | in erythroid | eukaryotic translation initiation factor 2A, 65kDa | Lu 2001 | |
Hypertonicity | increases phosphorylation of | EIF2AK1 | in erythroid | eukaryotic translation initiation factor 2-alpha kinase 1 | Lu 2001 | |
Hypertonicity | decreases phosphorylation of | CREB1 | at S133 | in fibroblasts | cAMP responsive element binding protein 1 | Gorbatenko 2011 |
Hypertonicity | decreases phosphorylation of | RPS6KA1 | in fibroblasts | ribosomal protein S6 kinase, 90kDa, polypeptide 1 | Gorbatenko 2011 | |
Hypertonicity | decreases phosphorylation of | RPS6KA5 | in fibroblasts | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | Gorbatenko 2011 | |
Hypertonicity | increases activity of | NFAT5 | in fibroblasts | nuclear factor of activated T-cells 5, tonicity-responsive | Lopez-Rodriguez 2004 | |
Hypertonicity | increases activity of | SRF | in fibroblasts | serum response factor (c-fos serum response element-binding transcription factor) | Gorbatenko 2011 | |
Hypertonicity | increases phosphorylation of | SRF | at S103 | in fibroblasts | serum response factor (c-fos serum response element-binding transcription factor) | Gorbatenko 2011 |
Hypertonicity | increases protein abundance of | MYL9 | in fibroblasts | myosin light chain 9 | Klein 1995 | |
Hypertonicity | decreases activity of | NKX2-1 | in glial BAS 8.1 | NK2 homeobox 1 | Kim 2008 | |
Hypertonicity | decreases mRNA abundance of | NKX2-1 | in glial BAS 8.1 | NK2 homeobox 1 | Kim 2008 | |
Hypertonicity | decreases protein abundance of | NKX2-1 | in glial BAS 8.1 | NK2 homeobox 1 | Kim 2008 | |
Hypertonicity | decreases transcription of | NKX2-1 | in glial BAS 8.1 | NK2 homeobox 1 | Kim 2008 | |
Hypertonicity | increases phosphorylation of | PTK2B | in GN4 | protein tyrosine kinase 2 beta | Yu 1998 | |
Hypertonicity | increases activity of | CASP1 | in GSM06 | caspase 1, apoptosis-related cysteine peptidase | Songhua 2006 | |
Hypertonicity | increases mRNA abundance of | IL1B | in GSM06 | interleukin 1, beta | Songhua 2006 | |
Hypertonicity | increases mRNA abundance of | ABCC5 | in H4IIE | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | IGFBP1 | in H4IIE | insulin-like growth factor binding protein 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | PCK2 | in H4IIE | phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Warskulat 1996 | |
Hypertonicity | increases mRNA abundance of | SLC6A9 | in H4IIE | solute carrier family 6 (neurotransmitter transporter, glycine), member 9 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | TAT | in H4IIE | tyrosine aminotransferase | Warskulat 1996 | |
Hypertonicity | increases protein abundance of | ABCC5 | in H4IIE | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | Schafer 2007 | |
Hypertonicity | increases activity of | MAPK1 | in H4IIE-C | mitogen-activated protein kinase 1 | Wiese 1998 | |
Hypertonicity | increases activity of | MAPK14 | in H4IIE-C | mitogen-activated protein kinase 14 | Wiese 1998 | |
Hypertonicity | increases activity of | MAPK9 | in H4IIE-C | mitogen-activated protein kinase 9 | Wiese 1998 | |
Hypertonicity | increases mRNA abundance of | DUSP1 | in H4IIE-C | dual specificity phosphatase 1 | Schliess 1998 | |
Hypertonicity | increases mRNA abundance of | DUSP1 | in H4IIE-C | dual specificity phosphatase 1 | Wiese 1998 | |
Hypertonicity | increases mRNA abundance of | JUN | in H4IIE-C | jun proto-oncogene | Wiese 1998 | |
Hypertonicity | increases phosphorylation of | JUN | in H4IIE-C | jun proto-oncogene | Wiese 1998 | |
Hypertonicity | decreases mRNA abundance of | BHMT | in H4IIE-C3 | betaine--homocysteine S-methyltransferase | Schafer 2007 | |
Hypertonicity | decreases protein abundance of | CCND1 | in H4IIE-C3 | cyclin D1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | HMGCR | in H4IIE-C3 | 3-hydroxy-3-methylglutaryl-CoA reductase | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ACAA1 | in H4IIE-C3 | acetyl-CoA acyltransferase 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ACTA1 | in H4IIE-C3 | actin, alpha 1, skeletal muscle | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ACTG1 | in H4IIE-C3 | actin, gamma 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ACADM | in H4IIE-C3 | acyl-CoA dehydrogenase, C-4 to C-12 straight chain | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | APRT | in H4IIE-C3 | adenine phosphoribosyltransferase | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ADH4 | in H4IIE-C3 | alcohol dehydrogenase 4 (class II), pi polypeptide | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ALDH2 | in H4IIE-C3 | aldehyde dehydrogenase 2 family (mitochondrial) | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ALDHLA4 | in H4IIE-C3 | aldehyde dehydrogenase family 1, subfamily A7 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | AHSG | in H4IIE-C3 | alpha-2-HS-glycoprotein | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ANXA4 | in H4IIE-C3 | annexin A4 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | APEX1 | in H4IIE-C3 | APEX nuclease (multifunctional DNA repair enzyme) 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | APOA1 | in H4IIE-C3 | apolipoprotein A-I | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | APOB | in H4IIE-C3 | apolipoprotein B | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | APOC3 | in H4IIE-C3 | apolipoprotein C-III | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | AQP8 | in H4IIE-C3 | aquaporin 8 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ARG1 | in H4IIE-C3 | arginase 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ATP1A1 | in H4IIE-C3 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ABCC2 | in H4IIE-C3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ABCD3 | in H4IIE-C3 | ATP-binding cassette, sub-family D (ALD), member 3 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | BLVRA | in H4IIE-C3 | biliverdin reductase A | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | BCKDK | in H4IIE-C3 | branched chain ketoacid dehydrogenase kinase | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | CDH6 | in H4IIE-C3 | cadherin 6, type 2, K-cadherin (fetal kidney) | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | CASP9 | in H4IIE-C3 | caspase 9, apoptosis-related cysteine peptidase | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | CTSH | in H4IIE-C3 | cathepsin H | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | CD24 | in H4IIE-C3 | CD24 molecule | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | CCS | in H4IIE-C3 | copper chaperone for superoxide dismutase | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | CDK2 | in H4IIE-C3 | cyclin-dependent kinase 2 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | CYB5R3 | in H4IIE-C3 | cytochrome b5 reductase 3 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | DNAJA1 | in H4IIE-C3 | DnaJ (Hsp40) homolog, subfamily A, member 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | DDC | in H4IIE-C3 | dopa decarboxylase (aromatic L-amino acid decarboxylase) | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | E2F5 | in H4IIE-C3 | E2F transcription factor 5, p130-binding | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | EGR1 | in H4IIE-C3 | early growth response 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ECHS1 | in H4IIE-C3 | enoyl-CoA hydratase, mitochondrial | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | FGG | in H4IIE-C3 | fibrinogen gamma chain | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | GFAP | in H4IIE-C3 | glial fibrillary acidic protein | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | GAD1 | in H4IIE-C3 | glutamate decarboxylase 1 (brain, 67kDa) | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | GLUL | in H4IIE-C3 | glutamate-ammonia ligase | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | HSP90AA1 | in H4IIE-C3 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | HNF4A | in H4IIE-C3 | hepatocyte nuclear factor 4, alpha | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | INSR | in H4IIE-C3 | insulin receptor | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ICAM1 | in H4IIE-C3 | intercellular adhesion molecule 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | JAK1 | in H4IIE-C3 | Janus kinase 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | KRT1 | in H4IIE-C3 | keratin 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | KRT2 | in H4IIE-C3 | keratin 2 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | KNG1 | in H4IIE-C3 | kininogen 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | MMP14 | in H4IIE-C3 | matrix metallopeptidase 14 (membrane-inserted) | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | MVK | in H4IIE-C3 | mevalonate kinase | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | MECR | in H4IIE-C3 | mitochondrial trans-2-enoyl-CoA reductase | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | MYO16 | in H4IIE-C3 | myosin XVI | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | NFIX | in H4IIE-C3 | nuclear factor I/X (CCAAT-binding transcription factor) | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | NFKBIA | in H4IIE-C3 | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | NR2F6 | in H4IIE-C3 | nuclear receptor subfamily 2, group F, member 6 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ODC1 | in H4IIE-C3 | ornithine decarboxylase 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | PAK2 | in H4IIE-C3 | p21 protein (Cdc42/Rac)-activated kinase 2 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | PTEN | in H4IIE-C3 | phosphatase and tensin homolog | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | PLA2G1B | in H4IIE-C3 | phospholipase A2, group IB (pancreas) | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | PLCG1 | in H4IIE-C3 | phospholipase C, gamma 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | PSEN1 | in H4IIE-C3 | presenilin 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | PCNA | in H4IIE-C3 | proliferating cell nuclear antigen | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | PRKCA | in H4IIE-C3 | protein kinase C, alpha | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | PRKCD | in H4IIE-C3 | protein kinase C, delta | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | PTP4A2 | in H4IIE-C3 | protein tyrosine phosphatase type IVA, member 2 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | PTMA | in H4IIE-C3 | prothymosin, alpha | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | PC | in H4IIE-C3 | pyruvate carboxylase | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | RXRG | in H4IIE-C3 | retinoid X receptor, gamma | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | SMAD1 | in H4IIE-C3 | SMAD family member 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | SLC29A1 | in H4IIE-C3 | solute carrier family 29 (equilibrative nucleoside transporter), member 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | SLC5A6 | in H4IIE-C3 | solute carrier family 5 (sodium/multivitamin and iodide cotransporter), member 6 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | SLC6A12 | in H4IIE-C3 | solute carrier family 6 (neurotransmitter transporter), member 12 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | SLC6A8 | in H4IIE-C3 | solute carrier family 6 (neurotransmitter transporter), member 8 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | SLC6A9 | in H4IIE-C3 | solute carrier family 6 (neurotransmitter transporter, glycine), member 9 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | SLC21A1 | in H4IIE-C3 | solute carrier organic anion transporter family, member 1a1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | SULT1B1 | in H4IIE-C3 | sulfotransferase family, cytosolic, 1B, member 1 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | SDC2 | in H4IIE-C3 | syndecan 2 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | TMSB10 | in H4IIE-C3 | thymosin beta 10 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | TOP2A | in H4IIE-C3 | topoisomerase (DNA) II alpha 170kDa | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | TF | in H4IIE-C3 | transferrin | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | TRIM28 | in H4IIE-C3 | tripartite motif containing 28 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | YWHAB | in H4IIE-C3 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | UGT1A2 | in H4IIE-C3 | UDP glucuronosyltransferase 1 family, polypeptide A2 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | UGT2B4 | in H4IIE-C3 | UDP glucuronosyltransferase 2 family, polypeptide B4 | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | UCP2 | in H4IIE-C3 | uncoupling protein 2 (mitochondrial, proton carrier) | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | CRK | in H4IIE-C3 | v-crk avian sarcoma virus CT10 oncogene homolog | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | ARAF | in H4IIE-C3 | v-raf murine sarcoma 3611 viral oncogene homolog | Schafer 2007 | |
Hypertonicity | increases mRNA abundance of | RELA | in H4IIE-C3 | v-rel avian reticuloendotheliosis viral oncogene homolog A | Schafer 2007 | |
Hypertonicity | increases protein abundance of | IGFBP1 | in H4IIE-C3 | insulin-like growth factor binding protein 1 | Schafer 2007 | |
Hypertonicity | increases phosphorylation of | PLA2G4A | in HaCaT | phospholipase A2, group IVA (cytosolic, calcium-dependent) | Rodriguez 2002 | |
Hypertonicity | increases activity of | AXL | in hCMEC/D3 | AXL receptor tyrosine kinas | Wilhelm 2008 | |
Hypertonicity | increases cleavage of | AXL | in hCMEC/D3 | AXL receptor tyrosine kinas | Wilhelm 2008 | |
Hypertonicity | increases phosphorylation of | AXL | in hCMEC/D3 | AXL receptor tyrosine kinas | Wilhelm 2008 | |
Hypertonicity | increases translocation of | AXL | in hCMEC/D3 | AXL receptor tyrosine kinas | Wilhelm 2008 | |
Hypertonicity | changes cytoplasmic protein abundance of | HMGCS1 | in HEK293 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ACO2 | in HEK293 | aconitase 2, mitochondria | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ACTB | in HEK293 | actin, beta | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ALDH18A1 | in HEK293 | aldehyde dehydrogenase 18 family, member A1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ALDOA | in HEK293 | aldolase A, fructose-bisphosphate | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ALDOC | in HEK293 | aldolase C, fructose-bisphosphate | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ANXA1 | in HEK293 | annexin A1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ANXA2 | in HEK293 | annexin A2 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ANXA5 | in HEK293 | annexin A5 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ASNS | in HEK293 | asparagine synthetase (glutamine-hydrolyzing) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ATXN10 | in HEK293 | ataxin 10 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ATP5A1 | in HEK293 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ATP5B | in HEK293 | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ATP1A1 | in HEK293 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | CANX | in HEK293 | calnexin | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | CALR | in HEK293 | calreticulin | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | CAD | in HEK293 | carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | CCT2 | in HEK293 | chaperonin containing TCP1, subunit 2 (beta) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | CS | in HEK293 | citrate synthase | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | C1QBP | in HEK293 | complement component 1, q subcomponent binding protein | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | CKB | in HEK293 | creatine kinase, brain | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | DYNC1H1 | in HEK293 | dynein, cytoplasmic 1, heavy chain 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ETFB | in HEK293 | electron-transfer-flavoprotein, beta polypeptide | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ENO1 | in HEK293 | enolase 1, (alpha) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | EPPK1 | in HEK293 | epiplakin 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | EEF1A1 | in HEK293 | eukaryotic translation elongation factor 1 alpha 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | EEF1G | in HEK293 | eukaryotic translation elongation factor 1 gamma | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | ESYT1 | in HEK293 | extended synaptotagmin-like protein 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | FSCN1 | in HEK293 | fascin actin-bundling protein 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | FASN | in HEK293 | fatty acid synthase | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | FLNA | in HEK293 | filamin A, alpha | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | GCN1L1 | in HEK293 | GCN1 general control of amino-acid synthesis 1-like 1 (yeast) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | GANAB | in HEK293 | glucosidase, alpha; neutral AB | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | GOT2 | in HEK293 | glutamic-oxaloacetic transaminase 2, mitochondrial | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | GAPDH | in HEK293 | glyceraldehyde-3-phosphate dehydrogenase | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | GNAI1 | in HEK293 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | GNAI3 | in HEK293 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | HSPD1 | in HEK293 | heat shock 60kDa protein 1 (chaperonin) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | HSPA1A | in HEK293 | heat shock 70kDa protein 1A | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | HSPA1L | in HEK293 | heat shock 70kDa protein 1-like | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | HSPA5 | in HEK293 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | HSPA9 | in HEK293 | heat shock 70kDa protein 9 (mortalin) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | HSP90B1 | in HEK293 | heat shock protein 90kDa beta (Grp94), member 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | HNRNPU | in HEK293 | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | HINT2 | in HEK293 | histidine triad nucleotide binding protein 2 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | HADHA | in HEK293 | hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase (trifunctional protein), alpha subunit | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | HYOU1 | in HEK293 | hypoxia up-regulated 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | IRS4 | in HEK293 | insulin receptor substrate 4 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | IGF2BP3 | in HEK293 | insulin-like growth factor 2 mRNA binding protein 3 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | KRT8 | in HEK293 | keratin 8 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | LDHA | in HEK293 | lactate dehydrogenase A | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | LDHB | in HEK293 | lactate dehydrogenase B | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | LAMP2 | in HEK293 | lysosomal-associated membrane protein 2 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | MDH2 | in HEK293 | malate dehydrogenase 2, NAD (mitochondrial) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | MSN | in HEK293 | moesin | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | MYH9 | in HEK293 | myosin, heavy chain 9, non-muscle | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | NASP | in HEK293 | nuclear autoantigenic sperm protein (histone-binding) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | NAP1L1 | in HEK293 | nucleosome assembly protein 1-like 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | PPIA | in HEK293 | peptidylprolyl isomerase A (cyclophilin A) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | PRDX3 | in HEK293 | peroxiredoxin 3 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | PFKP | in HEK293 | phosphofructokinase, platelet | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | PHGDH | in HEK293 | phosphoglycerate dehydrogenase | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | PSAT1 | in HEK293 | phosphoserine aminotransferase 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | PARP1 | in HEK293 | poly (ADP-ribose) polymerase 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | P4HB | in HEK293 | prolyl 4-hydroxylase, beta polypeptide | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | PRMT1 | in HEK293 | protein arginine methyltransferase 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | PDIA3 | in HEK293 | protein disulfide isomerase family A, member 3 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | PDIA4 | in HEK293 | protein disulfide isomerase family A, member 4 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | PDIA6 | in HEK293 | protein disulfide isomerase family A, member 6 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | PDHB | in HEK293 | pyruvate dehydrogenase (lipoamide) beta | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | PKM | in HEK293 | pyruvate kinase, muscle | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RAB10 | in HEK293 | RAB10, member RAS oncogene family | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RAB14 | in HEK293 | RAB14, member RAS oncogene family | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RAB1A | in HEK293 | RAB1A, member RAS oncogene family | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RAB1B | in HEK293 | RAB1B, member RAS oncogene family | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RAB35 | in HEK293 | RAB35, member RAS oncogene family | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RAB4A | in HEK293 | RAB4A, member RAS oncogene family | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RAB8A | in HEK293 | RAB8A, member RAS oncogene family | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RAB8B | in HEK293 | RAB8B, member RAS oncogene family | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RNH1 | in HEK293 | ribonuclease/angiogenin inhibitor 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RPN1 | in HEK293 | ribophorin I | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RPL12 | in HEK293 | ribosomal protein L12 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RPL17 | in HEK293 | ribosomal protein L17 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RPS14 | in HEK293 | ribosomal protein S14 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RPS24 | in HEK293 | ribosomal protein S24 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RPS27A | in HEK293 | ribosomal protein S27a | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RPS3A | in HEK293 | ribosomal protein S3A | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RPLP0 | in HEK293 | ribosomal protein, large, P0 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | RPLP1 | in HEK293 | ribosomal protein, large, P1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | SHMT2 | in HEK293 | serine hydroxymethyltransferase 2 (mitochondrial) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | SARS2 | in HEK293 | seryl-tRNA synthetase 2, mitochondrial | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | SRP14 | in HEK293 | signal recognition particle 14kDa (homologous Alu RNA binding protein) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | SLC25A4 | in HEK293 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | SLC25A5 | in HEK293 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | SLC25A6 | in HEK293 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | STOML2 | in HEK293 | stomatin (EPB72)-like 2 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | SDHA | in HEK293 | succinate dehydrogenase complex, subunit A, flavoprotein (Fp) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | SOD2 | in HEK293 | superoxide dismutase 2, mitochondrial | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | TXN | in HEK293 | thioredoxin | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | TALDO1 | in HEK293 | transaldolase 1 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | TAGLN2 | in HEK293 | transgelin 2 | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | TUFM | in HEK293 | Tu translation elongation factor, mitochondrial | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | TBCB | in HEK293 | tubulin folding cofactor B | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | TUBB3 | in HEK293 | tubulin, beta 3 class III | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | VPS29 | in HEK293 | vacuolar protein sorting 29 homolog (S. cerevisiae) | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | VARS | in HEK293 | valyl-tRNA synthetase | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | VIM | in HEK293 | vimentin | Li 2012 | |
Hypertonicity | changes cytoplasmic protein abundance of | YBX3 | in HEK293 | Y box binding protein 3 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | ACTB | in HEK293 | actin, beta | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | ACTN1 | in HEK293 | actinin, alpha 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | ACTN4 | in HEK293 | actinin, alpha 4 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | ADAR | in HEK293 | adenosine deaminase, RNA-specific | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | AHNAK | in HEK293 | AHNAK nucleoprotein | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | ANXA1 | in HEK293 | annexin A1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | ANXA2 | in HEK293 | annexin A2 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | APEX1 | in HEK293 | APEX nuclease (multifunctional DNA repair enzyme) 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | ATP5A1 | in HEK293 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | ATP5B | in HEK293 | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | ATAD3A | in HEK293 | ATPase family, AAA domain containing 3A | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | BRIX1 | in HEK293 | BRX1, biogenesis of ribosomes, homolog (S. cerevisiae) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | CANX | in HEK293 | calnexin | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | CALR | in HEK293 | calreticulin | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | CCT3 | in HEK293 | chaperonin containing TCP1, subunit 3 (gamma) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | CS | in HEK293 | citrate synthase | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | CLTC | in HEK293 | clathrin, heavy chain (Hc) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | CIRBP | in HEK293 | cold inducible RNA binding protein | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | C1QBP | in HEK293 | complement component 1, q subcomponent binding protein | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | CORO1C | in HEK293 | coronin, actin binding protein, 1C | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | CKB | in HEK293 | creatine kinase, brain | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | CKAP5 | in HEK293 | cytoskeleton associated protein 5 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | DDX17 | in HEK293 | DEAD (Asp-Glu-Ala-Asp) box helicase 17 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | DDX21 | in HEK293 | DEAD (Asp-Glu-Ala-Asp) box helicase 21 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | DDX3X | in HEK293 | DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | DDX5 | in HEK293 | DEAD (Asp-Glu-Ala-Asp) box helicase 5 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | DDX39A | in HEK293 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | DHX9 | in HEK293 | DEAH (Asp-Glu-Ala-His) box helicase 9 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | DEK | in HEK293 | DEK oncogene | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | DSP | in HEK293 | desmoplakin | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | DNMT1 | in HEK293 | DNA (cytosine-5-)-methyltransferase 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | DYNC1H1 | in HEK293 | dynein, cytoplasmic 1, heavy chain 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | ENO1 | in HEK293 | enolase 1, (alpha) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | EPB41L2 | in HEK293 | erythrocyte membrane protein band 4.1-like 2 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | EEF1A1 | in HEK293 | eukaryotic translation elongation factor 1 alpha 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | EEF1A2 | in HEK293 | eukaryotic translation elongation factor 1 alpha 2 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | EEF1D | in HEK293 | eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | EEF1G | in HEK293 | eukaryotic translation elongation factor 1 gamma | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | EEF2 | in HEK293 | eukaryotic translation elongation factor 2 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | EIF3A | in HEK293 | eukaryotic translation initiation factor 3, subunit A | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | FASN | in HEK293 | fatty acid synthase | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | FLNA | in HEK293 | filamin A, alpha | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | FLNC | in HEK293 | filamin C, gamma | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | GRWD1 | in HEK293 | glutamate-rich WD repeat containing 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | GAPDH | in HEK293 | glyceraldehyde-3-phosphate dehydrogenase | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HEATR1 | in HEK293 | HEAT repeat containing 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HSPD1 | in HEK293 | heat shock 60kDa protein 1 (chaperonin) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HSPA1A | in HEK293 | heat shock 70kDa protein 1A | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HSPA1L | in HEK293 | heat shock 70kDa protein 1-like | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HSPA2 | in HEK293 | heat shock 70kDa protein 2 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HSPA5 | in HEK293 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HSPA8 | in HEK293 | heat shock 70kDa protein 8 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HSPA9 | in HEK293 | heat shock 70kDa protein 9 (mortalin) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HSP90AA1 | in HEK293 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HSP90AB1 | in HEK293 | heat shock protein 90kDa alpha (cytosolic), class B member 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HNRNPAB | in HEK293 | heterogeneous nuclear ribonucleoprotein A/B | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HNRNPA1 | in HEK293 | heterogeneous nuclear ribonucleoprotein A1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HNRNPA2B1 | in HEK293 | heterogeneous nuclear ribonucleoprotein A2/B1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HNRNPA3 | in HEK293 | heterogeneous nuclear ribonucleoprotein A3 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HNRNPC | in HEK293 | heterogeneous nuclear ribonucleoprotein C (C1/C2) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HNRNPD | in HEK293 | heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HNRNPDL | in HEK293 | heterogeneous nuclear ribonucleoprotein D-like | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HNRNPF | in HEK293 | heterogeneous nuclear ribonucleoprotein F | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HNRNPH1 | in HEK293 | heterogeneous nuclear ribonucleoprotein H1 (H) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HNRNPM | in HEK293 | heterogeneous nuclear ribonucleoprotein M | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HK1 | in HEK293 | hexokinase 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HIST1H2BC | in HEK293 | histone cluster 1, H2bc | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | HIST1H4C | in HEK293 | histone cluster 1, H4c | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | ILF3 | in HEK293 | interleukin enhancer binding factor 3, 90kDa | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | KRT18 | in HEK293 | keratin 18 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | KRT19 | in HEK293 | keratin 19 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | KRT8 | in HEK293 | keratin 8 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | KHSRP | in HEK293 | KH-type splicing regulatory protein | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | LRRC59 | in HEK293 | leucine rich repeat containing 59 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | LIG3 | in HEK293 | ligase III, DNA, ATP-dependent | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MDH2 | in HEK293 | malate dehydrogenase 2, NAD (mitochondrial) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MKI67 | in HEK293 | marker of proliferation Ki-67 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MATR3 | in HEK293 | matrin 3 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MDC1 | in HEK293 | mediator of DNA-damage checkpoint 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MCM5 | in HEK293 | minichromosome maintenance complex component 5 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MCM6 | in HEK293 | minichromosome maintenance complex component 6 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MCM7 | in HEK293 | minichromosome maintenance complex component 7 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MYBBP1A | in HEK293 | MYB binding protein (P160) 1a | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MLLT4 | in HEK293 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MYL12A | in HEK293 | myosin regulatory light chain 12A | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MYH10 | in HEK293 | myosin, heavy chain 10, non-muscle | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MYH11 | in HEK293 | myosin, heavy chain 11, smooth muscle | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | MYH9 | in HEK293 | myosin, heavy chain 9, non-muscle | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | NONO | in HEK293 | non-POU domain containing, octamer-binding | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | NOLC1 | in HEK293 | nucleolar and coiled-body phosphoprotein 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | NCL | in HEK293 | nucleolin | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | NPM1 | in HEK293 | nucleophosmin (nucleolar phosphoprotein B23, numatrin) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | NUP155 | in HEK293 | nucleoporin 155kDa | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PAF1 | in HEK293 | Paf1, RNA polymerase II associated factor, homolog (S. cerevisiae) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PDS5A | in HEK293 | PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PPIA | in HEK293 | peptidylprolyl isomerase A (cyclophilin A) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PPIB | in HEK293 | peptidylprolyl isomerase B (cyclophilin B) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PARP1 | in HEK293 | poly (ADP-ribose) polymerase 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PTBP1 | in HEK293 | polypyrimidine tract binding protein 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | P4HB | in HEK293 | prolyl 4-hydroxylase, beta polypeptide | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PDIA3 | in HEK293 | protein disulfide isomerase family A, member 3 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PDIA4 | in HEK293 | protein disulfide isomerase family A, member 4 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PDIA6 | in HEK293 | protein disulfide isomerase family A, member 6 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PRKDC | in HEK293 | protein kinase, DNA-activated, catalytic polypeptide | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PPP1CA | in HEK293 | protein phosphatase 1, catalytic subunit, alpha isozyme | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PPP1CB | in HEK293 | protein phosphatase 1, catalytic subunit, beta isozyme | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PPP1CC | in HEK293 | protein phosphatase 1, catalytic subunit, gamma isozyme | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | PKM | in HEK293 | pyruvate kinase, muscle | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | QKI | in HEK293 | QKI, KH domain containing, RNA binding | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | RDX | in HEK293 | radixin | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | RANBP2 | in HEK293 | RAN binding protein 2 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | RCC2 | in HEK293 | regulator of chromosome condensation 2 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | RPN1 | in HEK293 | ribophorin I | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | RPLP0 | in HEK293 | ribosomal protein, large, P0 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | RPLP1 | in HEK293 | ribosomal protein, large, P1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | RBMX | in HEK293 | RNA binding motif protein, X-linked | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SHMT2 | in HEK293 | serine hydroxymethyltransferase 2 (mitochondrial) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SRSF1 | in HEK293 | serine/arginine-rich splicing factor 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SRP14 | in HEK293 | signal recognition particle 14kDa (homologous Alu RNA binding protein) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SNRNP200 | in HEK293 | small nuclear ribonucleoprotein 200kDa (U5) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SLC25A4 | in HEK293 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SLC25A5 | in HEK293 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SLC25A6 | in HEK293 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SPTAN1 | in HEK293 | spectrin, alpha, non-erythrocytic 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SPTBN1 | in HEK293 | spectrin, beta, non-erythrocytic 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SPTBN4 | in HEK293 | spectrin, beta, non-erythrocytic 4 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SF1 | in HEK293 | splicing factor 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SF3A1 | in HEK293 | splicing factor 3a, subunit 1, 120kDa | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SFPQ | in HEK293 | splicing factor proline/glutamine-rich | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SMCHD1 | in HEK293 | structural maintenance of chromosomes flexible hinge domain containing 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | SYNCRIP | in HEK293 | synaptotagmin binding, cytoplasmic RNA interacting protein | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TARS | in HEK293 | threonyl-tRNA synthetase | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TMPO | in HEK293 | thymopoietin | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TRIP12 | in HEK293 | thyroid hormone receptor interactor 12 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TJP2 | in HEK293 | tight junction protein 2 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TOP2A | in HEK293 | topoisomerase (DNA) II alpha 170kDa | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TAGLN2 | in HEK293 | transgelin 2 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TPR | in HEK293 | translocated promoter region, nuclear basket protein | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TCOF1 | in HEK293 | Treacher Collins-Franceschetti syndrome 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TRIM28 | in HEK293 | tripartite motif containing 28 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TPM1 | in HEK293 | tropomyosin 1 (alpha) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TPM3 | in HEK293 | tropomyosin 3 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TPM4 | in HEK293 | tropomyosin 4 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TUBA1A | in HEK293 | tubulin, alpha 1a | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TUBA1B | in HEK293 | tubulin, alpha 1b | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TUBA1C | in HEK293 | tubulin, alpha 1c | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TUBA8 | in HEK293 | tubulin, alpha 8 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TUBB2A | in HEK293 | tubulin, beta 2A class IIa | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TUBB3 | in HEK293 | tubulin, beta 3 class III | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TUBB4A | in HEK293 | tubulin, beta 4A class IVa | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TUBB4B | in HEK293 | tubulin, beta 4B class IVb | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TUBB6 | in HEK293 | tubulin, beta 6 class V | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | TUBB | in HEK293 | tubulin, beta class I | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | YWHAB | in HEK293 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | YWHAE | in HEK293 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | YWHAH | in HEK293 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | YWHAG | in HEK293 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | YWHAQ | in HEK293 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | YWHAZ | in HEK293 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | UBA1 | in HEK293 | ubiquitin-like modifier activating enzyme 1 | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | VIM | in HEK293 | vimentin | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | XRCC5 | in HEK293 | X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) | Li 2012 | |
Hypertonicity | changes nuclear protein abundance of | XRCC6 | in HEK293 | X-ray repair complementing defective repair in Chinese hamster cells 6 | Li 2012 | |
Hypertonicity | decreases activity of | DUSP1 | in HEK293 | dual specificity phosphatase 1 | Zhou 2008 | |
Hypertonicity | decreases activity of | GDPD5 | in HEK293 | glycerophosphodiester phosphodiesterase domain containing 5 | Gallazini 2008 | |
Hypertonicity | decreases activity of | GSK3B | in HEK293 | glycogen synthase kinase 3 beta | Zhou 2013 | |
Hypertonicity | decreases activity of | PTPN6 | in HEK293 | protein tyrosine phosphatase, non-receptor type 6 | Zhou 2010 | |
Hypertonicity | decreases activity of | RPS6KB1 | in HEK293 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 | Parrott 1999 | |
Hypertonicity | decreases activity of | TRPV4 | in HEK293 | transient receptor potential cation channel, subfamily V, member 4 | Stromann 2000 | |
Hypertonicity | decreases activity of | AKT1 | in HEK293 | v-akt murine thymoma viral oncogene homolog 1 | Meier 1998 | |
Hypertonicity | decreases mRNA abundance of | GDPD5 | in HEK293 | glycerophosphodiester phosphodiesterase domain containing 5 | Gallazini 2008 | |
Hypertonicity | decreases phosphorylation of | GDPD5 | at T587 | in HEK293 | glycerophosphodiester phosphodiesterase domain-containing protein 5 | Topanurak 2013 |
Hypertonicity | decreases phosphorylation of | RPS6KB1 | in HEK293 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 | Parrott 1999 | |
Hypertonicity | decreases translocation of | PTPN6 | in HEK293 | protein tyrosine phosphatase, non-receptor type 6 | Zhou 2010 | |
Hypertonicity | increases activity of | ATM | in HEK293 | ataxia telangiectasia mutated | Irarrazabal 2004 | |
Hypertonicity | increases activity of | ABL1 | in HEK293 | c-abl oncogene 1, non-receptor tyrosine kinase | Gallazzini 2010 | |
Hypertonicity | increases activity of | PPIP5K1 | in HEK293 | diphosphoinositol pentakisphosphate kinase 1 | Choi 2007 | |
Hypertonicity | increases activity of | PPIP5K2 | in HEK293 | diphosphoinositol pentakisphosphate kinase 2 | Choi 2007 | |
Hypertonicity | increases activity of | MAPK13 | in HEK293 | mitogen-activated protein kinase 13 | Zhou 2008 | |
Hypertonicity | increases activity of | MAPK14 | in HEK293 | mitogen-activated protein kinase 14 | Zhou 2008 | |
Hypertonicity | increases activity of | MAPK9 | in HEK293 | mitogen-activated protein kinase 9 | Kultz 1997 | |
Hypertonicity | increases activity of | MAP3K3 | in HEK293 | mitogen-activated protein kinase kinase kinase 3 | Fritz 2006 | |
Hypertonicity | increases activity of | MAP3K7 | in HEK293 | mitogen-activated protein kinase kinase kinase 7 | Huangfu 2006 | |
Hypertonicity | increases activity of | MAP3K7 | in HEK293 | mitogen-activated protein kinase kinase kinase 7 | Huangfu 2006 | |
Hypertonicity | increases activity of | OXSR1 | in HEK293 | oxidative stress responsive 1 | Zagorska 2007 | |
Hypertonicity | increases activity of | PIK3R1 | in HEK293 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Irarrazabal 2006 | |
Hypertonicity | increases activity of | PPP1CC | in HEK293 | protein phosphatase 1, catalytic subunit, gamma isozyme | Zhou 2013 | |
Hypertonicity | increases activity of | PPP1R3B | in HEK293 | protein phosphatase 1, regulatory subunit 3B | Zhou 2013 | |
Hypertonicity | increases activity of | STK39 | in HEK293 | serine threonine kinase 39 | Zagorska 2007 | |
Hypertonicity | increases activity of | RAC1 | in HEK293 | v-akt murine thymoma viral oncogene homolog 1 | Di Ciano 2002 | |
Hypertonicity | increases activity of | WNK1 | in HEK293 | WNK lysine deficient protein kinase 1 | Zagorska 2007 | |
Hypertonicity | increases activity of | PRKCA | in HEK293 | protein kinase C alpha type | Wang 2015 | |
Hypertonicity | increases binding of | CCM2 | in HEK293 | cerebral cavernous malformation 2 | Uhlik 2003 | |
Hypertonicity | increases binding of | PPP1CC | in HEK293 | protein phosphatase 1, catalytic subunit, gamma isozyme | Zhou 2013 | |
Hypertonicity | increases binding of | PPP1R3B | in HEK293 | protein phosphatase 1, regulatory subunit 3B | Zhou 2013 | |
Hypertonicity | increases phosphorylation of | ATM | at S1981 | in HEK293 | ataxia telangiectasia mutated | Irarrazabal 2004 |
Hypertonicity | increases phosphorylation of | ABL1 | at Y245, Y412 | in HEK293 | c-abl oncogene 1, non-receptor tyrosine kinase | Gallazzini 2010 |
Hypertonicity | increases phosphorylation of | GSK3B | at S9 | in HEK293 | glycogen synthase kinase 3 beta | Zhou 2013 |
Hypertonicity | increases phosphorylation of | MAPK13 | in HEK293 | mitogen-activated protein kinase 13 | Zhou 2008 | |
Hypertonicity | increases phosphorylation of | MAPK14 | in HEK293 | mitogen-activated protein kinase 14 | Zhou 2008 | |
Hypertonicity | increases phosphorylation of | MAPK9 | in HEK293 | mitogen-activated protein kinase 9 | Kultz 1997 | |
Hypertonicity | increases phosphorylation of | MAP3K3 | at S526 | in HEK293 | mitogen-activated protein kinase kinase kinase 3 | Fritz 2006 |
Hypertonicity | increases phosphorylation of | MAP3K7 | in HEK293 | mitogen-activated protein kinase kinase kinase 7 | Huangfu 2006 | |
Hypertonicity | increases phosphorylation of | NFAT5 | at S135 or T135 | in HEK293 | nuclear factor of activated T-cells 5, tonicity-responsive | Gallazzini 2011 |
Hypertonicity | increases phosphorylation of | NFAT5 | at Y143 | in HEK293 | nuclear factor of activated T-cells 5, tonicity-responsive | Gallazzini 2010 |
Hypertonicity | increases phosphorylation of | OXSR1 | in HEK293 | oxidative stress responsive 1 | Zagorska 2007 | |
Hypertonicity | increases phosphorylation of | PIK3R1 | at Y508 | in HEK293 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Irarrazabal 2006 |
Hypertonicity | increases phosphorylation of | PTPN6 | at S591 | in HEK293 | protein tyrosine phosphatase, non-receptor type 6 | Zhou 2010 |
Hypertonicity | increases phosphorylation of | STK39 | in HEK293 | serine threonine kinase 39 | Zagorska 2007 | |
Hypertonicity | increases phosphorylation of | WNK1 | in HEK293 | WNK lysine deficient protein kinase 1 | Zagorska 2007 | |
Hypertonicity | increases phosphorylation of | AKAP12 | at S188 | in HEK293 | A kinase (PRKA) anchor protein 12 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ACACA | at S117 | in HEK293 | acetyl-CoA carboxylase alpha | Wang 2014 |
Hypertonicity | increases phosphorylation of | ABLIM1 | at S655 | in HEK293 | actin binding LIM protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ATF2 | at T69, T71 | in HEK293 | activating transcription factor 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ATF7 | at T51, T53 | in HEK293 | activating transcription factor 7 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ATF7IP | at S113, T118 | in HEK293 | activating transcription factor 7 interacting protein | Wang 2014 |
Hypertonicity | increases phosphorylation of | ACBD5 | at T172 | in HEK293 | acyl-CoA binding domain containing 5 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ADAR | at T601 | in HEK293 | adenosine deaminase, RNA-specific | Wang 2014 |
Hypertonicity | increases phosphorylation of | AFF4 | at S1043 | in HEK293 | AF4/FMR2 family, member 4 | Wang 2014 |
Hypertonicity | increases phosphorylation of | AHNAK | at S5749, S5763 | in HEK293 | AHNAK nucleoprotein | Wang 2014 |
Hypertonicity | increases phosphorylation of | AKT1S1 | at S212 | in HEK293 | AKT1 substrate 1 (proline-rich) | Wang 2014 |
Hypertonicity | increases phosphorylation of | ALKBH5 | at S384 | in HEK293 | alkB, alkylation repair homolog 5 (E. coli) | Wang 2014 |
Hypertonicity | increases phosphorylation of | AHSG | at S138 | in HEK293 | alpha-2-HS-glycoprotein | Wang 2014 |
Hypertonicity | increases phosphorylation of | ANLN | at S792 | in HEK293 | anillin, actin binding protein | Wang 2014 |
Hypertonicity | increases phosphorylation of | ANKS1A | at S677 | in HEK293 | ankyrin repeat and sterile alpha motif domain containing 1A | Wang 2014 |
Hypertonicity | increases phosphorylation of | ACIN1 | at S240 | in HEK293 | apoptotic chromatin condensation inducer 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | AGFG1 | at T177, S181 | in HEK293 | ArfGAP with FG repeats 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ARID1A | at S696 | in HEK293 | AT rich interactive domain 1A (SWI-like) | Wang 2014 |
Hypertonicity | increases phosphorylation of | ATM | at S1981 | in HEK293 | ataxia telangiectasia mutated | Wang 2014 |
Hypertonicity | increases phosphorylation of | ATP2B1 | at S1155 | in HEK293 | ATPase, Ca++ transporting, plasma membrane 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | BCL7C | at S126 | in HEK293 | B-cell CLL/lymphoma 7C | Wang 2014 |
Hypertonicity | increases phosphorylation of | BAG3 | at S284, S289 | in HEK293 | BCL2-associated athanogene 3 | Wang 2014 |
Hypertonicity | increases phosphorylation of | BAZ1B | at S947 | in HEK293 | bromodomain adjacent to zinc finger domain, 1B | Wang 2014 |
Hypertonicity | increases phosphorylation of | BRWD1 | at S1475 | in HEK293 | bromodomain and WD repeat domain containing 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | BRD2 | at S298 | in HEK293 | bromodomain containing 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | BUD13 | at S325 | in HEK293 | BUD13 homolog (S. cerevisiae | Wang 2014 |
Hypertonicity | increases phosphorylation of | CAMSAP2 | at S1008 | in HEK293 | calmodulin regulated spectrin-associated protein family, member 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | CAMSAP3 | at S395 | in HEK293 | calmodulin regulated spectrin-associated protein family, member 3 | Wang 2014 |
Hypertonicity | increases phosphorylation of | CREB5 | at T59, T61 | in HEK293 | cAMP responsive element binding protein 5 | Wang 2014 |
Hypertonicity | increases phosphorylation of | CLIP1 | at S204 | in HEK293 | CAP-GLY domain containing linker protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | CAAP1 | at T90 | in HEK293 | caspase activity and apoptosis inhibitor 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | CTNNB1 | at S552 | in HEK293 | catenin (cadherin-associated protein), beta 1, 88kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | CTNND1 | at S167 | in HEK293 | catenin (cadherin-associated protein), delta 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | CDC42EP3 | at S89 | in HEK293 | CDC42 effector protein (Rho GTPase binding) 3 | Wang 2014 |
Hypertonicity | increases phosphorylation of | CEP170B | at S1065 | in HEK293 | centrosomal protein 170B | Wang 2014 |
Hypertonicity | increases phosphorylation of | CEP170 | at S1160, S1165 | in HEK293 | centrosomal protein 170kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | CHAF1B | at T433 | in HEK293 | chromatin assembly factor 1, subunit B (p60) | Wang 2014 |
Hypertonicity | increases phosphorylation of | C18ORF25 | at S66 | in HEK293 | chromosome 18 open reading frame 25 | Wang 2014 |
Hypertonicity | increases phosphorylation of | C2ORF49 | at S189, T198 | in HEK293 | chromosome 2 open reading frame 49 | Wang 2014 |
Hypertonicity | increases phosphorylation of | CLASRP | at S547 | in HEK293 | CLK4-associating serine/arginine rich protein | Wang 2014 |
Hypertonicity | increases phosphorylation of | CTTN | at T401 | in HEK293 | cortactin | Wang 2014 |
Hypertonicity | increases phosphorylation of | CNNM3 | at S652 | in HEK293 | cyclin M3 | Wang 2014 |
Hypertonicity | increases phosphorylation of | CDK13 | at S1054, T1058 | in HEK293 | cyclin-dependent kinase 13 | Wang 2014 |
Hypertonicity | increases phosphorylation of | CLASP1 | at S1071 | in HEK293 | cytoplasmic linker associated protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | DPF2 | at S142 | in HEK293 | D4, zinc and double PHD fingers family 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | DCAF6 | at S336 | in HEK293 | DDB1 and CUL4 associated factor 6 | Wang 2014 |
Hypertonicity | increases phosphorylation of | DAXX | at S683 | in HEK293 | death-domain associated protein | Wang 2014 |
Hypertonicity | increases phosphorylation of | DCP1A | at S525, T531 | in HEK293 | decapping mRNA 1A | Wang 2014 |
Hypertonicity | increases phosphorylation of | DCP1B | at S275 | in HEK293 | decapping mRNA 1B | Wang 2014 |
Hypertonicity | increases phosphorylation of | DOCK7 | at S30 | in HEK293 | dedicator of cytokinesis 7 | Wang 2014 |
Hypertonicity | increases phosphorylation of | DENND4C | at S1184 | in HEK293 | DENN/MADD domain containing 4C | Wang 2014 |
Hypertonicity | increases phosphorylation of | DENND5B | at S178 | in HEK293 | DENN/MADD domain containing 5B | Wang 2014 |
Hypertonicity | increases phosphorylation of | DNTTIP2 | at S117 | in HEK293 | deoxynucleotidyltransferase, terminal, interacting protein 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | DSG2 | at S680 | in HEK293 | desmoglein 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | DLG1 | at S575 | in HEK293 | discs, large homolog 1 (Drosophila) | Wang 2014 |
Hypertonicity | increases phosphorylation of | DMAP1 | at T445 | in HEK293 | DNA methyltransferase 1 associated protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | DNM1L | at S616 | in HEK293 | dynamin 1-like | Wang 2014 |
Hypertonicity | increases phosphorylation of | DYNC1LI1 | at S510, S516 | in HEK293 | dynein, cytoplasmic 1, light intermediate chain 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | EFHD2 | at S74 | in HEK293 | EF-hand domain family, member D2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | EGLN1 | at S125 | in HEK293 | egl-9 family hypoxia-inducible factor 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | EDC3 | at S131 | in HEK293 | enhancer of mRNA decapping 3 | Wang 2014 |
Hypertonicity | increases phosphorylation of | EGFR | at T693 | in HEK293 | epidermal growth factor receptor | Wang 2014 |
Hypertonicity | increases phosphorylation of | EPS15 | at S796 | in HEK293 | epidermal growth factor receptor pathway substrate 15 | Wang 2014 |
Hypertonicity | increases phosphorylation of | EPPK1 | at S2716 or S3250 or S3784 or S4318 or S4852 | in HEK293 | epiplakin 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | EPB41L3 | at S460, T469 | in HEK293 | erythrocyte membrane protein band 4.1-like 3 | Wang 2014 |
Hypertonicity | increases phosphorylation of | EIF3B | at S119 | in HEK293 | eukaryotic translation initiation factor 3, subunit B | Wang 2014 |
Hypertonicity | increases phosphorylation of | EIF4G2 | at T508 | in HEK293 | eukaryotic translation initiation factor 4 gamma, 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | EIF4EBP1 | at S65 | in HEK293 | eukaryotic translation initiation factor 4E binding protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | FAM117B | at S10 | in HEK293 | family with sequence similarity 117, member B | Wang 2014 |
Hypertonicity | increases phosphorylation of | FAM122A | at S147 | in HEK293 | family with sequence similarity 122A | Wang 2014 |
Hypertonicity | increases phosphorylation of | FRMD6 | at S514, S517 | in HEK293 | FERM domain containing 6 | Wang 2014 |
Hypertonicity | increases phosphorylation of | FARP1 | at S427 | in HEK293 | FERM, RhoGEF (ARHGEF) and pleckstrin domain protein 1 (chondrocyte-derived) | Wang 2014 |
Hypertonicity | increases phosphorylation of | FOXC1 | at S235, S241 | in HEK293 | forkhead box C1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | FOXK2 | at S398 | in HEK293 | forkhead box K2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | GPKOW | at T216 | in HEK293 | G patch domain and KOW motifs | Wang 2014 |
Hypertonicity | increases phosphorylation of | GPR137C | at S357 | in HEK293 | G protein-coupled receptor 137C | Wang 2014 |
Hypertonicity | increases phosphorylation of | GAL | at S116 | in HEK293 | galanin/GMAP prepropeptide | Wang 2014 |
Hypertonicity | increases phosphorylation of | GATAD2B | at S333 | in HEK293 | GATA zinc finger domain containing 2B | Wang 2014 |
Hypertonicity | increases phosphorylation of | GMIP | at S234 | in HEK293 | GEM interacting protein | Wang 2014 |
Hypertonicity | increases phosphorylation of | GTF2F1 | at T389 | in HEK293 | general transcription factor IIF, polypeptide 1, 74kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | GORASP2 | at T433 | in HEK293 | golgi reassembly stacking protein 2, 55kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | GIGYF2 | at S26 | in HEK293 | GRB10 interacting GYF protein 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | HAUS6 | at T584 | in HEK293 | HAUS augmin-like complex, subunit 6 | Wang 2014 |
Hypertonicity | increases phosphorylation of | HEATR6 | at S643 | in HEK293 | HEAT repeat containing 6 | Wang 2014 |
Hypertonicity | increases phosphorylation of | HSPB1 | at S82 | in HEK293 | heat shock 27kDa protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | HECTD4 | at S1325 | in HEK293 | HECT domain containing E3 ubiquitin protein ligase 4 | Wang 2014 |
Hypertonicity | increases phosphorylation of | HELB | at S967 | in HEK293 | helicase (DNA) B | Wang 2014 |
Hypertonicity | increases phosphorylation of | HELZ | at S1763 | in HEK293 | helicase with zinc finger | Wang 2014 |
Hypertonicity | increases phosphorylation of | HPS5 | at S420 | in HEK293 | Hermansky-Pudlak syndrome 5 | Wang 2014 |
Hypertonicity | increases phosphorylation of | HNRNPM | at S579 | in HEK293 | heterogeneous nuclear ribonucleoprotein M | Wang 2014 |
Hypertonicity | increases phosphorylation of | HNRNPUL1 | at S718 | in HEK293 | heterogeneous nuclear ribonucleoprotein U-like 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | HMGA1 | at S91, S92 | in HEK293 | high mobility group AT-hook 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | HMGA2 | at S101 | in HEK293 | high mobility group AT-hook 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | HCFC1 | at S598 | in HEK293 | host cell factor C1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | HTT | at S1876 | in HEK293 | huntingtin | Wang 2014 |
Hypertonicity | increases phosphorylation of | INCENP | at S306, S312 | in HEK293 | inner centromere protein antigens 135/155kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | IRS2 | at S365 | in HEK293 | insulin receptor substrate 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | INTS1 | at T83 | in HEK293 | integrator complex subunit 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ICE1 | at S255 | in HEK293 | interactor of little elongator complex ELL subunit 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | JUN | at S243 | in HEK293 | jun proto-oncogene | Wang 2014 |
Hypertonicity | increases phosphorylation of | KHDRBS1 | at S20 | in HEK293 | KH domain containing, RNA binding, signal transduction associated 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | KIAA1211 | at S1017 | in HEK293 | KIAA1211 | Wang 2014 |
Hypertonicity | increases phosphorylation of | KIAA1432 | at S1017 | in HEK293 | KIAA1432 | Wang 2014 |
Hypertonicity | increases phosphorylation of | KIAA1522 | at S917, S921 | in HEK293 | KIAA1522 | Wang 2014 |
Hypertonicity | increases phosphorylation of | KSR1 | at S197 | in HEK293 | kinase suppressor of ras 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | KIF13B | at S1644 | in HEK293 | kinesin family member 13B | Wang 2014 |
Hypertonicity | increases phosphorylation of | KANK2 | at S375 | in HEK293 | KN motif and ankyrin repeat domains 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | LARP1 | at S689, S697 | in HEK293 | La ribonucleoprotein domain family, member 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | LARP4 | at S593 | in HEK293 | La ribonucleoprotein domain family, member 4 | Wang 2014 |
Hypertonicity | increases phosphorylation of | LAMTOR1 | at S97 | in HEK293 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | LRRFIP1 | at S88 | in HEK293 | leucine rich repeat (in FLII) interacting protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | LRRC16A | at S968 | in HEK293 | leucine rich repeat containing 16A | Wang 2014 |
Hypertonicity | increases phosphorylation of | LIG1 | at S76 | in HEK293 | ligase I, DNA, ATP-dependent | Wang 2014 |
Hypertonicity | increases phosphorylation of | LMO7 | at S533 | in HEK293 | LIM domain 7 | Wang 2014 |
Hypertonicity | increases phosphorylation of | LIMK1 | at S310 | in HEK293 | LIM domain kinase 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | MAF1 | at S75 | in HEK293 | MAF1 homolog (S. cerevisiae) | Wang 2014 |
Hypertonicity | increases phosphorylation of | MAP7D1 | at S460 | in HEK293 | MAP7 domain containing 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | MKI67 | at T1764 | in HEK293 | marker of proliferation Ki-67 | Wang 2014 |
Hypertonicity | increases phosphorylation of | MED24 | at S860 | in HEK293 | mediator complex subunit 24 | Wang 2014 |
Hypertonicity | increases phosphorylation of | MDC1 | at S1605 | in HEK293 | mediator of DNA-damage checkpoint 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | MPST | at S15 | in HEK293 | mercaptopyruvate sulfurtransferase | Wang 2014 |
Hypertonicity | increases phosphorylation of | MTA1 | at T578 | in HEK293 | metastasis associated 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | MICALL1 | at S484, S486 | in HEK293 | MICAL-like 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | MAP1B | at S1779, S1782, T1788 | in HEK293 | microtubule-associated protein 1B | Wang 2014 |
Hypertonicity | increases phosphorylation of | MAP2 | at T306 | in HEK293 | microtubule-associated protein 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | MAP4 | at S1073 | in HEK293 | microtubule-associated protein 4 | Wang 2014 |
Hypertonicity | increases phosphorylation of | MAP7 | at S209 | in HEK293 | microtubule-associated protein 7 | Wang 2014 |
Hypertonicity | increases phosphorylation of | MAVS | at S222 | in HEK293 | mitochondrial antiviral signaling protein | Wang 2014 |
Hypertonicity | increases phosphorylation of | MAPK14 | at Y182 | in HEK293 | mitogen-activated protein kinase 14 | Wang 2014 |
Hypertonicity | increases phosphorylation of | MLLT4 | at S1731 (record removed) | in HEK293 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | Wang 2014 |
Hypertonicity | increases phosphorylation of | MYH9 | at S1943 | in HEK293 | myosin, heavy chain 9, non-muscle | Wang 2014 |
Hypertonicity | increases phosphorylation of | MTMR3 | at Y614 | in HEK293 | myotubularin related protein 3 | Wang 2014 |
Hypertonicity | increases phosphorylation of | NCKAP5L | at S477 | in HEK293 | NCK-associated protein 5-like | Wang 2014 |
Hypertonicity | increases phosphorylation of | NELFE | at S353 | in HEK293 | negative elongation factor complex member E | Wang 2014 |
Hypertonicity | increases phosphorylation of | NEK4 | at S340 | in HEK293 | NIMA-related kinase 4 | Wang 2014 |
Hypertonicity | increases phosphorylation of | NUCKS1 | at S214 | in HEK293 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | NFRKB | at S253 | in HEK293 | nuclear factor related to kappaB binding protein | Wang 2014 |
Hypertonicity | increases phosphorylation of | NFX1 | at S50 | in HEK293 | nuclear transcription factor, X-box binding 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | NUP153 | at S257 | in HEK293 | nucleoporin 153kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | NUP188 | at S1709, S1717 | in HEK293 | nucleoporin 188kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | NUP35 | at S259 | in HEK293 | nucleoporin 35kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | NUP50 | at S221 | in HEK293 | nucleoporin 50kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | NAP1L1 | at T62 | in HEK293 | nucleosome assembly protein 1-like 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | OSBPL11 | at S181 | in HEK293 | oxysterol binding protein-like 11 | Wang 2014 |
Hypertonicity | increases phosphorylation of | PARD3 | at S973 | in HEK293 | par-3 family cell polarity regulator | Wang 2014 |
Hypertonicity | increases phosphorylation of | PALM | at T141, T145 | in HEK293 | paralemmin | Wang 2014 |
Hypertonicity | increases phosphorylation of | PAGR1 | at S237 | in HEK293 | PAXIP1 associated glutamate-rich protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | PDZD8 | at S521 | in HEK293 | PDZ domain containing 8 | Wang 2014 |
Hypertonicity | increases phosphorylation of | PCM1 | at S93 | in HEK293 | pericentriolar material 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | PEX1 | at S1181 | in HEK293 | peroxisomal biogenesis factor 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | PKP2 | at S329 | in HEK293 | plakophilin 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | PKP3 | at S238 | in HEK293 | plakophilin 3 | Wang 2014 |
Hypertonicity | increases phosphorylation of | PHIP | at S1315 | in HEK293 | pleckstrin homology domain interacting protein | Wang 2014 |
Hypertonicity | increases phosphorylation of | PHLDB1 | at S1017 | in HEK293 | pleckstrin homology-like domain, family B, member 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | PARN | at S102 | in HEK293 | poly(A)-specific ribonuclease | Wang 2014 |
Hypertonicity | increases phosphorylation of | PCBP2 | at S189 | in HEK293 | poly(rC) binding protein 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | POLR2A | at S1878, T1884 | in HEK293 | polymerase (RNA) II (DNA directed) polypeptide A, 220kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | PNKP | at T118, T122 | in HEK293 | polynucleotide kinase 3'-phosphatase | Wang 2014 |
Hypertonicity | increases phosphorylation of | KCTD12 | at S187 | in HEK293 | potassium channel tetramerization domain containing 12 | Wang 2014 |
Hypertonicity | increases phosphorylation of | PAWR | at T230 | in HEK293 | PRKC, apoptosis, WT1, regulator | Wang 2014 |
Hypertonicity | increases phosphorylation of | PRRC2A | at S1147 | in HEK293 | proline-rich coiled-coil 2A | Wang 2014 |
Hypertonicity | increases phosphorylation of | PML | at S518, S527 | in HEK293 | promyelocytic leukemia | Wang 2014 |
Hypertonicity | increases phosphorylation of | PSMD1 | at T273 | in HEK293 | proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | PSMF1 | at S153 | in HEK293 | proteasome (prosome, macropain) inhibitor subunit 1 (PI31) | Wang 2014 |
Hypertonicity | increases phosphorylation of | PSMA5 | at S56 | in HEK293 | proteasome (prosome, macropain) subunit, alpha type, 5 | Wang 2014 |
Hypertonicity | increases phosphorylation of | PATL1 | at S179, S184 | in HEK293 | protein associated with topoisomerase II homolog 1 (yeast) | Wang 2014 |
Hypertonicity | increases phosphorylation of | PRKAA1 | at S501, T505 | in HEK293 | protein kinase, AMP-activated, alpha 1 catalytic subunit | Wang 2014 |
Hypertonicity | increases phosphorylation of | PRKAA2 | at S377 | in HEK293 | protein kinase, AMP-activated, alpha 2 catalytic subunit | Wang 2014 |
Hypertonicity | increases phosphorylation of | PPP1R10 | at S313 | in HEK293 | protein phosphatase 1, regulatory subunit 10 | Wang 2014 |
Hypertonicity | increases phosphorylation of | PPP1R12C | at S427 | in HEK293 | protein phosphatase 1, regulatory subunit 12C | Wang 2014 |
Hypertonicity | increases phosphorylation of | PPFIA1 | at S666 | in HEK293 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RALGPS2 | at S296, S308 | in HEK293 | Ral GEF with PH domain and SH3 binding motif 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RALGAPA1 | at S775 | in HEK293 | Ral GTPase activating protein, alpha subunit 1 (catalytic) | Wang 2014 |
Hypertonicity | increases phosphorylation of | RPTOR | at S859, S863 | in HEK293 | regulatory associated protein of MTOR, complex 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RFX7 | at S1178 | in HEK293 | regulatory factor X, 7 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RB1 | at S249, T252 | in HEK293 | retinoblastoma 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RBBP6 | at S1145 | in HEK293 | retinoblastoma binding protein 6 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RBL1 | at S1037, S1041 | in HEK293 | retinoblastoma-like 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RBL2 | at S413, T417 | in HEK293 | retinoblastoma-like 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RAI14 | at S281 | in HEK293 | retinoic acid induced 14 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ARHGAP1 | at S51 | in HEK293 | Rho GTPase activating protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ARHGAP27 | at S125 | in HEK293 | Rho GTPase activating protein 27 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ARHGEF40 | at S262 | in HEK293 | Rho guanine nucleotide exchange factor (GEF) 40 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ARHGEF18 | at S1103 | in HEK293 | Rho/Rac guanine nucleotide exchange factor (GEF) 18 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RAVER1 | at T480 | in HEK293 | ribonucleoprotein, PTB-binding 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RPL4 | at S295 | in HEK293 | ribosomal protein L4 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RPS10 | at S146 | in HEK293 | ribosomal protein S10 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RRP1B | at S732, S736 | in HEK293 | ribosomal RNA processing 1B | Wang 2014 |
Hypertonicity | increases phosphorylation of | RNF20 | at S138 | in HEK293 | ring finger protein 20, E3 ubiquitin protein ligase | Wang 2014 |
Hypertonicity | increases phosphorylation of | RBM10 | at S89 | in HEK293 | RNA binding motif protein 10 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RBM25 | at S677 | in HEK293 | RNA binding motif protein 25 | Wang 2014 |
Hypertonicity | increases phosphorylation of | RBMX | at S328 | in HEK293 | RNA binding motif protein, X-linked | Wang 2014 |
Hypertonicity | increases phosphorylation of | SACS | at S4264 | in HEK293 | sacsin molecular chaperone | Wang 2014 |
Hypertonicity | increases phosphorylation of | SLTM | at S1002 | in HEK293 | SAFB-like, transcription modulator | Wang 2014 |
Hypertonicity | increases phosphorylation of | SAFB | at S604 | in HEK293 | scaffold attachment factor B | Wang 2014 |
Hypertonicity | increases phosphorylation of | SCYL3 | at S653 | in HEK293 | SCY1-like 3 (S. cerevisiae) | Wang 2014 |
Hypertonicity | increases phosphorylation of | SEPT7 | at T426 | in HEK293 | septin-7 | Wang 2014 |
Hypertonicity | increases phosphorylation of | SQSTM1 | at T269 | in HEK293 | sequestosome 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | SRRM2 | at S1541, S1552 | in HEK293 | serine/arginine repetitive matrix 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | SH2D4A | at S315 | in HEK293 | SH2 domain containing 4A | Wang 2014 |
Hypertonicity | increases phosphorylation of | SHKBP1 | at S587 | in HEK293 | SH3KBP1 binding protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | STAT1 | at S727 | in HEK293 | signal transducer and activator of transcription 1, 91kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | SIPA1 | at S53 | in HEK293 | signal-induced proliferation-associated 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | SNRNP70 | at S410 | in HEK293 | small nuclear ribonucleoprotein 70kDa (U1) | Wang 2014 |
Hypertonicity | increases phosphorylation of | SMG9 | at S32 | in HEK293 | SMG9 nonsense mediated mRNA decay factor | Wang 2014 |
Hypertonicity | increases phosphorylation of | SON | at S1769 | in HEK293 | SON DNA binding protein | Wang 2014 |
Hypertonicity | increases phosphorylation of | SPECC1 | at S131 | in HEK293 | sperm antigen with calponin homology and coiled-coil domains 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | SF3B2 | at S307, S309 | in HEK293 | splicing factor 3b, subunit 2, 145kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | SFPQ | at S273 | in HEK293 | splicing factor proline/glutamine-rich | Wang 2014 |
Hypertonicity | increases phosphorylation of | SHB | at S388 | in HEK293 | Src homology 2 domain containing adaptor protein B | Wang 2014 |
Hypertonicity | increases phosphorylation of | STIM1 | at S575 | in HEK293 | stromal interaction molecule 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | SENP3 | at S188 | in HEK293 | SUMO1/sentrin/SMT3 specific peptidase 3 | Wang 2014 |
Hypertonicity | increases phosphorylation of | SUPT5H | at S666 | in HEK293 | suppressor of Ty 5 homolog (S. cerevisiae) | Wang 2014 |
Hypertonicity | increases phosphorylation of | SUV39H1 | at S391 | in HEK293 | suppressor of variegation 3-9 homolog 1 (Drosophila) | Wang 2014 |
Hypertonicity | increases phosphorylation of | STX17 | at S289 | in HEK293 | syntaxin 17 | Wang 2014 |
Hypertonicity | increases phosphorylation of | TNKS1BP1 | at S1385 | in HEK293 | tankyrase 1 binding protein 1, 182kDa | Wang 2014 |
Hypertonicity | increases phosphorylation of | TOM1 | at S462 | in HEK293 | target of myb1 (chicken) | Wang 2014 |
Hypertonicity | increases phosphorylation of | TBC1D10B | at T148 | in HEK293 | TBC1 domain family, member 10B | Wang 2014 |
Hypertonicity | increases phosphorylation of | TBC1D22A | at S167 | in HEK293 | TBC1 domain family, member 22A | Wang 2014 |
Hypertonicity | increases phosphorylation of | TANC1 | at S269 | in HEK293 | tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | TMPO | at T74 | in HEK293 | thymopoietin | Wang 2014 |
Hypertonicity | increases phosphorylation of | TNIK | at S707 | in HEK293 | TRAF2 and NCK interacting kinase | Wang 2014 |
Hypertonicity | increases phosphorylation of | TCEB3 | at S542 | in HEK293 | transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A) | Wang 2014 |
Hypertonicity | increases phosphorylation of | TLE3 | at T334 | in HEK293 | transducin-like enhancer of split 3, homolog of Drosophila E(spl) | Wang 2014 |
Hypertonicity | increases phosphorylation of | TPR | at S1185 | in HEK293 | translocated promoter region, nuclear basket protein | Wang 2014 |
Hypertonicity | increases phosphorylation of | TMEM230 | at S23 | in HEK293 | transmembrane protein 230 | Wang 2014 |
Hypertonicity | increases phosphorylation of | TCOF1 | at T983 (record removed) | in HEK293 | Treacher Collins-Franceschetti syndrome 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | TTK | at S281 | in HEK293 | TTK protein kinase | Wang 2014 |
Hypertonicity | increases phosphorylation of | TPD52L2 | at S189 | in HEK293 | tumor protein D52-like 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | TP53BP1 | at S557 | in HEK293 | tumor protein p53 binding protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | TP53BP2 | at S433 | in HEK293 | tumor protein p53 binding protein, 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | UBAP2L | at S608, S609 | in HEK293 | ubiquitin associated protein 2-like | Wang 2014 |
Hypertonicity | increases phosphorylation of | UBR1 | at T21 | in HEK293 | ubiquitin protein ligase E3 component n-recognin 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | USP42 | at S856 | in HEK293 | ubiquitin specific peptidase 42 | Wang 2014 |
Hypertonicity | increases phosphorylation of | USP47 | at S822 | in HEK293 | ubiquitin specific peptidase 47 | Wang 2014 |
Hypertonicity | increases phosphorylation of | USP8 | at S389 | in HEK293 | ubiquitin specific peptidase 8 | Wang 2014 |
Hypertonicity | increases phosphorylation of | UBXN7 | at S288 | in HEK293 | UBX domain protein 7 | Wang 2014 |
Hypertonicity | increases phosphorylation of | WDHD1 | at S260 | in HEK293 | WD repeat and HMG-box DNA binding protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | WIZ | at S249 | in HEK293 | widely interspaced zinc finger motifs | Wang 2014 |
Hypertonicity | increases phosphorylation of | YBX1 | at S165 | in HEK293 | Y box binding protein 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | YEATS2 | at S519 | in HEK293 | YEATS domain containing 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ZC3H18 | at T796 | in HEK293 | zinc finger CCCH-type containing 18 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ZC3HAV1 | at S386 | in HEK293 | zinc finger CCCH-type, antiviral 1 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ZNF446 | at S137 | in HEK293 | zinc finger protein 446 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ZNF462 | at S688 | in HEK293 | zinc finger protein 462 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ZNF687 | at S253 | in HEK293 | zinc finger protein 687 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ZNF768 | at S90, S97 | in HEK293 | zinc finger protein 768 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ZFC3H1 | at S352 | in HEK293 | zinc finger, C3H1-type containing | Wang 2014 |
Hypertonicity | increases phosphorylation of | ZCCHC8 | at S658 | in HEK293 | zinc finger, CCHC domain containing 8 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ZFYVE16 | at S939 | in HEK293 | zinc finger, FYVE domain containing 16 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ZMYM2 | at S305 | in HEK293 | zinc finger, MYM-type 2 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ZSWIM8 | at S1161 | in HEK293 | zinc finger, SWIM-type containing 8 | Wang 2014 |
Hypertonicity | increases phosphorylation of | ZYX | at S344 | in HEK293 | zyxin | Wang 2014 |
Hypertonicity | increases translocation of | WNK1 | in HEK293 | WNK lysine deficient protein kinase 1 | Zagorska 2007 | |
Hypertonicity | Increases ubiquitination | PTEN | in HEK293T | phosphatase and tensin homolog | Maccario 2010 | |
Hypertonicity | decreases phosphorylation of | NFAT5 | in HeLa | nuclear factor of activated T-cells 5, tonicity-responsive | Xu 2008 | |
Hypertonicity | decreases phosphorylation of | PIP5K1B | in HeLa | phosphatidylinositol-4-phosphate 5-kinase, type I, beta | Yamamoto 2006 | |
Hypertonicity | increases activity of | EGFR | in HeLa | epidermal growth factor receptor | Rosette 1996 | |
Hypertonicity | increases activity of | GSK3B | in HeLa | glycogen synthase kinase 3 beta | Perez-Pinera 2006 | |
Hypertonicity | increases activity of | HSF1 | in HeLa | heat shock transcription factor 1 | Caruccio 1997 | |
Hypertonicity | increases activity of | PIP5K1B | in HeLa | phosphatidylinositol-4-phosphate 5-kinase, type I, beta | Yamamoto 2006 | |
Hypertonicity | increases activity of | TNFRSF1A | in HeLa | tumor necrosis factor receptor superfamily, member 1A | Rosette 1996 | |
Hypertonicity | increases mRNA abundance of | NFAT5 | in HeLa | nuclear factor of activated T-cells 5, tonicity-responsive | Ko 2000 | |
Hypertonicity | increases phosphorylation of | TNFRSF1A | in HeLa | tumor necrosis factor receptor superfamily, member 1A | Rosette 1996 | |
Hypertonicity | increases translocation of | EGFR | in HeLa | epidermal growth factor receptor | Rosette 1996 | |
Hypertonicity | increases translocation of | IL1R1 | in HeLa | interleukin 1 receptor, type I | Rosette 1996 | |
Hypertonicity | increases translocation of | NFAT5 | in HeLa | nuclear factor of activated T-cells 5, tonicity-responsive | Ko 2000 | |
Hypertonicity | increases translocation of | NFAT5 | in HeLa | nuclear factor of activated T-cells 5, tonicity-responsive | Tong 2006 | |
Hypertonicity | increases translocation of | NCL | in HeLa | nucleolin | Yang 2008 | |
Hypertonicity | increases translocation of | PIP5K1B | in HeLa | phosphatidylinositol-4-phosphate 5-kinase, type I, beta | Yamamoto 2006 | |
Hypertonicity | increases translocation of | RAN | in HeLa | RAN, member RAS oncogene family | Kelley 2007 | |
Hypertonicity | increases translocation of | STAT3 | in HeLa | signal transducer and activator of transcription 3 (acute-phase response factor) | Gastios 1998 | |
Hypertonicity | increases translocation of | TNFRSF1A | in HeLa | tumor necrosis factor receptor superfamily, member 1A | Rosette 1996 | |
Hypertonicity | decreases mRNA abundance of | CYP1A2 | in hepatocytes | cytochrome P450, family 1, subfamily A, polypeptide 2 | Ito 2007 | |
Hypertonicity | decreases mRNA abundance of | CYP2D6 | in hepatocytes | cytochrome P450, family 2, subfamily D, polypeptide 6 | Ito 2007 | |
Hypertonicity | increases activity of | CYP2E1 | in hepatocytes | cytochrome P450 2E1 precursor | Ito 2007 | |
Hypertonicity | increases binding of | EGFR | in hepatocytes | epidermal growth factor receptor | Reinehr 2004 | |
Hypertonicity | increases binding of | FAS | in hepatocytes | Fas cell surface death receptor | Reinehr 2004 | |
Hypertonicity | increases mRNA abundance of | CYP1A1 | in hepatocytes | cytochrome P450, family 1, subfamily A, polypeptide 1 | Ito 2007 | |
Hypertonicity | increases mRNA abundance of | CYP2E1 | in hepatocytes | cytochrome P450, family 2, subfamily E, polypeptide 1 | Ito 2007 | |
Hypertonicity | increases mRNA abundance of | UGT2B4 | in hepatocytes | UDP glucuronosyltransferase 2 family, polypeptide B4 | Ito 2007 | |
Hypertonicity | increases phosphorylation of | EGFR | in hepatocytes | epidermal growth factor receptor | Reinehr 2004 | |
Hypertonicity | increases phosphorylation of | FAS | in hepatocytes | Fas cell surface death receptor | Reinehr 2004 | |
Hypertonicity | increases phosphorylation of | FYN | in hepatocytes | FYN oncogene related to SRC, FGR, YES | Reinehr 2004 | |
Hypertonicity | increases phosphorylation of | LCK | in hepatocytes | lymphocyte-specific protein tyrosine kinase | Reinehr 2004 | |
Hypertonicity | increases phosphorylation of | NCF1 | in hepatocytes | neutrophil cytosol factor 1 | Reinehr 2006 | |
Hypertonicity | increases phosphorylation of | YES1 | in hepatocytes | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | Reinehr 2004 | |
Hypertonicity | increases protein abundance of | CYP2E1 | in hepatocytes | cytochrome P450, family 2, subfamily E, polypeptide 1 | Ito 2007 | |
Hypertonicity | increases activity of | NFAT5 | in HepG2 | nuclear factor of activated T-cells 5, tonicity-responsive | Ferraris 2002 | |
Hypertonicity | increases activity of | PRKACA | in HepG2 | protein kinase, cAMP-dependent, catalytic, alpha | Ferraris 2002 | |
Hypertonicity | increases activity of | SLC6A6 | in HepG2 | solute carrier family 6 (neurotransmitter transporter), member 6 | Satsu 2006 | |
Hypertonicity | increases mRNA abundance of | CDO1 | in HepG2 | cysteine dioxygenase type 1 | Satsu 2006 | |
Hypertonicity | increases mRNA abundance of | CYP3A5 | in HepG2 | cytochrome P450, family 3, subfamily A, polypeptide 5 | Kosuge 2007 | |
Hypertonicity | increases mRNA abundance of | CYP3A7 | in HepG2 | cytochrome P450, family 3, subfamily A, polypeptide 7 | Kosuge 2007 | |
Hypertonicity | increases mRNA abundance of | PTGER3 | in HepG2 | prostaglandin E receptor 3 (subtype EP3) | Kim 2009 | |
Hypertonicity | increases mRNA abundance of | PTGER4 | in HepG2 | prostaglandin E receptor 4 (subtype EP4) | Kim 2009 | |
Hypertonicity | increases mRNA abundance of | SLC6A6 | in HepG2 | solute carrier family 6 (neurotransmitter transporter), member 6 | Satsu 2006 | |
Hypertonicity | increases phosphorylation of | NFAT5 | in HepG2 | nuclear factor of activated T-cells 5, tonicity-responsive | Ferraris 2002 | |
Hypertonicity | increases phosphorylation of | STAT1 | in HepG2 | signal transducer and activator of transcription 1, 91kDa | Gatsios 1998 | |
Hypertonicity | increases protein abundance of | CYP3A5 | in HepG2 | cytochrome P450, family 3, subfamily A, polypeptide 5 | Kosuge 2007 | |
Hypertonicity | increases protein abundance of | CYP3A7 | in HepG2 | cytochrome P450, family 3, subfamily A, polypeptide 7 | Kosuge 2007 | |
Hypertonicity | increases protein abundance of | PTGER3 | in HepG2 | prostaglandin E receptor 3 (subtype EP3) | Kim 2009 | |
Hypertonicity | increases protein abundance of | PTGER4 | in HepG2 | prostaglandin E receptor 4 (subtype EP4) | Kim 2009 | |
Hypertonicity | increases protein abundance of | SLC6A6 | in HepG2 | solute carrier family 6 (neurotransmitter transporter), member 6 | Satsu 2006 | |
Hypertonicity | increases translocation of | NFAT5 | in HepG2 | nuclear factor of activated T-cells 5, tonicity-responsive | Ferraris 2002 | |
Hypertonicity | increases activity of | STAT1 | in HepG2 | signal transducer and activator of transcription 1, 91kDa | Gastios 1998 | |
Hypertonicity | increases activity of | STAT3 | in HepG2 | signal transducer and activator of transcription 3 (acute-phase response factor) | Gastios 1998 | |
Hypertonicity | increases activity of | SLC6A6 | in HepG2 | solute carrier family 6 (neurotransmitter transporter), member 6 | Takashi 2004 | |
Hypertonicity | increases binding of | STAT1 | in HepG2 | signal transducer and activator of transcription 1, 91kDa | Gastios 1999 | |
Hypertonicity | increases binding of | STAT3 | in HepG2 | signal transducer and activator of transcription 3 (acute-phase response factor) | Gastios 1999 | |
Hypertonicity | increases mRNA abundance of | SLC6A6 | in HepG2 | solute carrier family 6 (neurotransmitter transporter), member 6 | Takashi 2004 | |
Hypertonicity | increases phosphorylation of | JAK2 | in HepG2 | Janus kinase 2 | Gastios 1998 | |
Hypertonicity | increases phosphorylation of | STAT1 | at Y701 | in HepG2 | signal transducer and activator of transcription 1, 91kDa | Gastios 1998 |
Hypertonicity | increases phosphorylation of | STAT3 | at Y705 | in HepG2 | signal transducer and activator of transcription 3 (acute-phase response factor) | Gastios 1998 |
Hypertonicity | increases phosphorylation of | TYK2 | in HepG2 | tyrosine kinase 2 | Gastios 1998 | |
Hypertonicity | increases protein abundance of | SLC6A6 | in HepG2 | solute carrier family 6 (neurotransmitter transporter), member 6 | Takashi 2004 | |
Hypertonicity | increases transcription of | SLC6A6 | in HepG2 | solute carrier family 6 (neurotransmitter transporter), member 6 | Takashi 2004 | |
Hypertonicity | increases mRNA abundance of | SLC5A3 | in HK-2 | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 | Hsin 2011 | |
Hypertonicity | increases mRNA abundance of | SLC6A6 | in HK-2 | solute carrier family 6 (neurotransmitter transporter), member 6 | Hsin 2011 | |
Hypertonicity | increases protein abundance of | DDC | in HK-2 | dopa decarboxylase (aromatic L-amino acid decarboxylase) | Hsin 2011 | |
Hypertonicity | increases activity of | NFKB1 | in HT29 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Nemeth 2002 | |
Hypertonicity | increases binding of | CXCL1 | in HT29 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | Nemeth 2002 | |
Hypertonicity | increases binding of | NFKB1 | in HT29 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | Nemeth 2002 | |
Hypertonicity | increases mRNA abundance of | IL8 | in HT29 | interleukin 8 | Nemeth 2002 | |
Hypertonicity | increases protein abundance of | IL8 | in HT29 | interleukin 8 | Nemeth 2002 | |
Hypertonicity | decreases mRNA abundance of | CFTR | in HT-29 | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Baudouin-Legros 1999 | |
Hypertonicity | increases mRNA abundance of | GUCA2A | in HT-29-18-N2 | guanylate cyclase activator 2A (guanylin) | Steinbrecher 2002 | |
Hypertonicity | increases mRNA abundance of | GUCA2B | in HT-29-18-N2 | guanylate cyclase activator 2B (uroguanylin) | Steinbrecher 2002 | |
Hypertonicity | increases activity of | SRC | in IEC-18 cells | v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog | Lunn 2007 | |
Hypertonicity | increases phosphorylation of | SRC | in IEC-18 cells | v-src avian sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog | Lunn 2007 | |
Hypertonicity | decreases mRNA abundance of | CES3 | in IM | carboxylesterase 3 | McReynolds 2005 | |
Hypertonicity | decreases mRNA abundance of | GSTA4 | in IM | glutathione S-transferase alpha 4 | McReynolds 2005 | |
Hypertonicity | decreases mRNA abundance of | LCN2 | in IM | lipocalin 2 | McReynolds 2005 | |
Hypertonicity | decreases mRNA abundance of | MATN2 | in IM | matrilin 2 | McReynolds 2005 | |
Hypertonicity | decreases mRNA abundance of | TGFA | in IM | transforming growth factor, alpha | McReynolds 2005 | |
Hypertonicity | increases activity of | CDK5 | in IM | cyclin-dependent kinase 5 | Gallazzini 2011 | |
Hypertonicity | increases activity of | PTGER3 | in IM | prostaglandin E receptor 3 (subtype EP3) | Kim 2009 | |
Hypertonicity | increases activity of | PTGER4 | in IM | prostaglandin E receptor 4 (subtype EP4) | Kim 2009 | |
Hypertonicity | increases activity of | SOD2 | in IM | superoxide dismutase 2, mitochondrial | Zhou 2012 | |
Hypertonicity | increases mRNA abundance of | ATF4 | in IM | activating transcription factor 4 | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | AK2 | in IM | adenylate kinase 2 | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | ADH6 | in IM | alcohol dehydrogenase 6 (class V) | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | AKR1B1 | in IM | aldo-keto reductase family 1, member B1 (aldose reductase) | Cowley 1990 | |
Hypertonicity | increases mRNA abundance of | ALDOB | in IM | aldolase B, fructose-bisphosphate | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | ATP5C1 | in IM | ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | ATP5L | in IM | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | ATP6V0E1 | in IM | ATPase, H+ transporting, lysosomal 9kDa, V0 subunit e1 | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | CD9 | in IM | CD9 molecule | Sheikh-Hamad 2000 | |
Hypertonicity | increases mRNA abundance of | CLN3 | in IM | ceroid-lipofuscinosis, neuronal 3 | Stein 2010 | |
Hypertonicity | increases mRNA abundance of | HSPH1 | in IM | heat shock 105kDa/110kDa protein 1 | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | ITGB2 | in IM | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | Sheikh-Hamad 2000 | |
Hypertonicity | increases mRNA abundance of | LYAR | in IM | Ly1 antibody reactive | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | LY6G5B | in IM | lymphocyte antigen 6 complex, locus G5B | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | NDUFA1 | in IM | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | NUPR1 | in IM | nuclear protein, transcriptional regulator, 1 | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | PTGER3 | in IM | prostaglandin E receptor 3 (subtype EP3) | Kim 2009 | |
Hypertonicity | increases mRNA abundance of | PTGER4 | in IM | prostaglandin E receptor 4 (subtype EP4) | Kim 2009 | |
Hypertonicity | increases mRNA abundance of | PTK2 | in IM | protein tyrosine kinase 2 | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | PTP4A2 | in IM | protein tyrosine phosphatase type IVA, member 2 | McReynolds 2005 | |
Hypertonicity | increases mRNA abundance of | RASD1 | in IM | RAS, dexamethasone-induced 1 | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | SLC25A21 | in IM | solute carrier family 25 (mitochondrial oxoadipate carrier), member 21 | McReynolds 2005 | |
Hypertonicity | increases phosphorylation of | NFAT5 | at S135 or T135 | in IM | nuclear factor of activated T-cells 5, tonicity-responsive | Gallazzini 2011 |
Hypertonicity | increases protein abundance of | AKR1B1 | in IM | aldo-keto reductase family 1, member B1 (aldose reductase) | Cowley 1990 | |
Hypertonicity | increases protein abundance of | CD9 | in IM | CD9 molecule | Sheikh-Hamad 2000 | |
Hypertonicity | increases protein abundance of | PTGER4 | in IM | prostaglandin E receptor 4 (subtype EP4) | Kim 2009 | |
Hypertonicity | increases protein abundance of | S100A4 | in IM | S100 calcium binding protein A4 | Rivard 2007 | |
Hypertonicity | increases protein abundance of | SOD2 | in IM | superoxide dismutase 2, mitochondrial | Zhou 2012 | |
Hypertonicity | increases mRNA abundance of | EDN1 | in IM tubules | endothelin 1 | Yang 1993 | |
Hypertonicity | increases protein abundance of | EDN1 | in IM tubules | endothelin 1 | Yang 1993 | |
Hypertonicity | decreases activity of | NOS2 | in IMCD | nitric oxide synthase 2, inducible | Chen 2002 | |
Hypertonicity | decreases activity of | NOS3 | in IMCD | nitric oxide synthase 3 (endothelial cell) | Chen 2002 | |
Hypertonicity | decreases mRNA abundance of | NOS2 | in IMCD | nitric oxide synthase 2, inducible | Chen 2002 | |
Hypertonicity | decreases mRNA abundance of | NOS3 | in IMCD | nitric oxide synthase 3 (endothelial cell) | Chen 2002 | |
Hypertonicity | decreases protein abundance of | NOS2 | in IMCD | nitric oxide synthase 2, inducible | Chen 2002 | |
Hypertonicity | decreases protein abundance of | NOS3 | in IMCD | nitric oxide synthase 3 (endothelial cell) | Chen 2002 | |
Hypertonicity | increases activity of | MAPK1 | in IMCD | mitogen-activated protein kinase 1 | Chen 2002 | |
Hypertonicity | increases activity of | MAPK11 | in IMCD | mitogen-activated protein kinase 11 | Chen 2002 | |
Hypertonicity | increases activity of | MAPK8 | in IMCD | mitogen-activated protein kinase 8 | Chen 2002 | |
Hypertonicity | increases activity of | NPR1 | in IMCD | natriuretic peptide receptor 1 | Chen 2002 | |
Hypertonicity | increases mRNA abundance of | ATP1A1 | in IMCD | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Ohtaka 1996 | |
Hypertonicity | increases mRNA abundance of | ATP1B1 | in IMCD | ATPase, Na+/K+ transporting, beta 1 polypeptide | Ohtaka 1996 | |
Hypertonicity | increases mRNA abundance of | NPR1 | in IMCD | natriuretic peptide receptor 1 | Chen 2002 | |
Hypertonicity | increases phosphorylation of | MAPK11 | in IMCD | mitogen-activated protein kinase 11 | Chen 2002 | |
Hypertonicity | increases transcription of | NPR1 | in IMCD | natriuretic peptide receptor 1 | Chen 2002 | |
Hypertonicity | increases mRNA abundance of | THBS1 | in IMCD3 | thrombospondin 1 | Nahm 2002 | |
Hypertonicity | increases activity of | NFAT5 | in jurkat | nuclear factor of activated T-cells 5, tonicity-responsive | Lopez-Rodriguez 2001 | |
Hypertonicity | increases mRNA abundance of | LTB | in jurkat | lymphotoxin beta (TNF superfamily, member 3) | Lopez-Rodriguez 2001 | |
Hypertonicity | increases protein abundance of | NFAT5 | in jurkat | nuclear factor of activated T-cells 5, tonicity-responsive | Lopez-Rodriguez 2001 | |
Hypertonicity | increases translocation of | NFAT5 | in jurkat | nuclear factor of activated T-cells 5, tonicity-responsive | Lopez-Rodriguez 2001 | |
Hypertonicity | increases mRNA abundance of | CCNC | in KBEF | cyclin C | Oh 2006 | |
Hypertonicity | increases protein abundance of | CCNC | in KBEF | cyclin C | Oh 2006 | |
Hypertonicity | increases protein abundance of | SLC6A6 | in KBEF | solute carrier family 6 (neurotransmitter transporter), member 6 | Oh 2006 | |
Hypertonicity | increases mRNA abundance of | FLG | in keratinocyte | filaggrin | Mammone 2008 | |
Hypertonicity | increases mRNA abundance of | IVL | in keratinocyte | involucrin | Mammone 2008 | |
Hypertonicity | increases mRNA abundance of | KRT1 | in keratinocyte | keratin 1 | Mammone 2008 | |
Hypertonicity | increases mRNA abundance of | KRT10 | in keratinocyte | keratin 10 | Mammone 2008 | |
Hypertonicity | increases mRNA abundance of | TGM1 | in keratinocyte | transglutaminase 1 | Mammone 2008 | |
Hypertonicity | increases protein abundance of | AQP3 | in keratinocyte | aquaporin 3 (Gill blood group) | Herrlich 2004 | |
Hypertonicity | increases protein abundance of | IVL | in keratinocyte | involucrin | Mammone 2008 | |
Hypertonicity | increases protein abundance of | KRT1 | in keratinocyte | keratin 1 | Mammone 2008 | |
Hypertonicity | increases protein abundance of | KRT10 | in keratinocyte | keratin 10 | Mammone 2008 | |
Hypertonicity | increases mRNA abundance of | TNF | in L929 | tumor necrosis factor | Esensten 2005 | |
Hypertonicity | increases protein abundance of | NFAT5 | in L929 | nuclear factor of activated T-cells 5, tonicity-responsive | Esensten 2005 | |
Hypertonicity | increases transcription of | TNF | in L929 | tumor necrosis factor | Esensten 2005 | |
Hypertonicity | increases protein abundance of | AQP5 | in lacrimal gland | aquaporin 5 | Hoffert 2000 | |
Hypertonicity | decreases activity of | SLC9A3 | in LLC-PK1 | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Soleimani 1998 | |
Hypertonicity | increases activity of | CFL1 | in LLC-PK1 | cofilin 1 (non-muscle) | Thirone 2009 | |
Hypertonicity | increases activity of | PAK2 | in LLC-PK1 | p21 protein (Cdc42/Rac)-activated kinase 2 | Thirone 2009 | |
Hypertonicity | increases activity of | RAC1 | in LLC-PK1 | v-akt murine thymoma viral oncogene homolog 1 | Thirone 2009 | |
Hypertonicity | increases phosphorylation of | CFL1 | in LLC-PK1 | cofilin 1 (non-muscle) | Thirone 2009 | |
Hypertonicity | increases phosphorylation of | LIMK2 | in LLC-PK1 | LIM domain kinase 2 | Thirone 2009 | |
Hypertonicity | increases phosphorylation of | MYL9 | in LLC-PK1 | myosin light chain 9 | Di Ciano-Oliveira 2003 | |
Hypertonicity | increases phosphorylation of | PAK2 | in LLC-PK1 | p21 protein (Cdc42/Rac)-activated kinase 2 | Thirone 2009 | |
Hypertonicity | increases protein abundance of | MIOX | in LLC-PK1 | myo-inositol oxygenase | Prabhu 2005 | |
Hypertonicity | increases protein abundance of | YWHAQ | in LLC-PK1 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta | Niswander 2006 | |
Hypertonicity | increases transcription of | MIOX | in LLC-PK1 | myo-inositol oxygenase | Prabhu 2005 | |
Hypertonicity | increases translocation of | ACTR3 | in LLC-PK1 | ARP3 actin-related protein 3 homolog (yeast) | Di Ciano 2002 | |
Hypertonicity | increases activity of | NFAT5 | in lymphocytes | nuclear factor of activated T-cells 5, tonicity-responsive | Drews-Elger 2009 | |
Hypertonicity | increases mRNA abundance of | GADD45A | in Lymphocytes | growth arrest and DNA-damage-inducible, alpha | Drews-Elger 2009 | |
Hypertonicity | increases mRNA abundance of | GADD45B | in Lymphocytes | growth arrest and DNA-damage-inducible, beta | Drews-Elger 2009 | |
Hypertonicity | increases mRNA abundance of | HSPA1A | in Lymphocytes | heat shock 70kDa protein 1A | Drews-Elger 2009 | |
Hypertonicity | increases mRNA abundance of | SLC38A2 | in Lymphocytes | solute carrier family 38, member 2 | Drews-Elger 2009 | |
Hypertonicity | increases mRNA abundance of | SLC5A3 | in Lymphocytes | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 | Drews-Elger 2009 | |
Hypertonicity | increases mRNA abundance of | SLC6A6 | in Lymphocytes | solute carrier family 6 (neurotransmitter transporter), member 6 | Drews-Elger 2009 | |
Hypertonicity | increases phosphorylation of | TP53 | at S15 | in Lymphocytes | tumor protein p53 | Drews-Elger 2009 |
Hypertonicity | increases protein abundance of | CCNA2 | in Lymphocytes | cyclin A2 | Drews-Elger 2009 | |
Hypertonicity | increases protein abundance of | CCNB1 | in Lymphocytes | cyclin B1 | Drews-Elger 2009 | |
Hypertonicity | increases protein abundance of | CCNE1 | in Lymphocytes | cyclin E1 | Drews-Elger 2009 | |
Hypertonicity | increases activity of | CFL1 | in MDCK | cofilin 1 (non-muscle) | Thirone 2009 | |
Hypertonicity | increases activity of | COX2 | in MDCK | cytochrome c oxidase subunit II | Favale 2009 | |
Hypertonicity | increases activity of | EGR1 | in MDCK | early growth response 1 | Cohen 1991 | |
Hypertonicity | increases activity of | MAPK1 | in MDCK | mitogen-activated protein kinase 1 | Terada 1994 | |
Hypertonicity | increases activity of | MAP2K1 | in MDCK | mitogen-activated protein kinase kinase 1 | Terada 1994 | |
Hypertonicity | increases activity of | MAP2K2 | in MDCK | mitogen-activated protein kinase kinase 2 | Itoh 1994 | |
Hypertonicity | increases activity of | NFAT5 | in MDCK | nuclear factor of activated T-cells 5, tonicity-responsive | Miyakawa 1999 | |
Hypertonicity | increases activity of | PNPLA6 | in MDCK | patatin-like phospholipase domain containing 6 | Kwon 1995 | |
Hypertonicity | increases activity of | RPS6KB1 | in MDCK | ribosomal protein S6 kinase, 70kDa, polypeptide 1 | Terada 1994 | |
Hypertonicity | increases activity of | SLC5A3 | in MDCK | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 | Yamauchi 1993 | |
Hypertonicity | increases activity of | SLC6A12 | in MDCK | solute carrier family 6 (neurotransmitter transporter), member 12 | Kapus 1999 | |
Hypertonicity | increases mRNA abundance of | CD9 | in MDCK | CD9 molecule | Shiekh-Hamad 1996 | |
Hypertonicity | increases mRNA abundance of | COX2 | in MDCK | cytochrome c oxidase subunit II | Favale 2009 | |
Hypertonicity | increases mRNA abundance of | EGR1 | in MDCK | early growth response 1 | Cohen 1991 | |
Hypertonicity | increases mRNA abundance of | FOS | in MDCK | FBJ murine osteosarcoma viral oncogene homolog | Cohen 1991 | |
Hypertonicity | increases mRNA abundance of | HSPA4 | in MDCK | heat shock 70kDa protein 4 | Cohen 1991 | |
Hypertonicity | increases mRNA abundance of | ITGB2 | in MDCK | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | Shiekh-Hamad 1997 | |
Hypertonicity | increases mRNA abundance of | NFAT5 | in MDCK | nuclear factor of activated T-cells 5, tonicity-responsive | Woo 2000 | |
Hypertonicity | increases mRNA abundance of | SLC5A3 | in MDCK | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 | Yamauchi 1993 | |
Hypertonicity | increases mRNA abundance of | SLC6A12 | in MDCK | solute carrier family 6 (neurotransmitter transporter), member 12 | Kapus 1999 | |
Hypertonicity | increases mRNA abundance of | STC1 | in MDCK | stanniocalcin 1 | Sheikh-Hamad 2000 | |
Hypertonicity | increases mRNA abundance of | STC2 | in MDCK | stanniocalcin 2 | Shiekh-Hamad 1999 | |
Hypertonicity | increases nuclear localization of | NFAT5 | in MDCK | nuclear factor of activated T-cells 5, tonicity-responsive | Woo 2000 | |
Hypertonicity | increases phosphorylation of | CFL1 | in MDCK | cofilin 1 (non-muscle) | Thirone 2009 | |
Hypertonicity | increases phosphorylation of | EGFR | in MDCK | epidermal growth factor receptor | Kuper 2009 | |
Hypertonicity | increases phosphorylation of | MAPK1 | in MDCK | mitogen-activated protein kinase 1 | Kuper 2009 | |
Hypertonicity | increases phosphorylation of | MAPK1 | in MDCK | mitogen-activated protein kinase 1 | Terada 1994 | |
Hypertonicity | increases phosphorylation of | MAPK14 | in MDCK | mitogen-activated protein kinase 14 | Kuper 2009 | |
Hypertonicity | increases phosphorylation of | MAPK3 | in MDCK | mitogen-activated protein kinase 3 | Kuper 2009 | |
Hypertonicity | increases phosphorylation of | MAP2K2 | in MDCK | mitogen-activated protein kinase kinase 2 | Itoh 1994 | |
Hypertonicity | increases phosphorylation of | NFAT5 | in MDCK | nuclear factor of activated T-cells 5, tonicity-responsive | Dahl 2001 | |
Hypertonicity | increases phosphorylation of | RAF1 | in MDCK | v-raf-1 murine leukemia viral oncogene homolog 1 | Terada 1994 | |
Hypertonicity | increases protein abundance of | CD9 | in MDCK | CD9 molecule | Shiekh-Hamad 1996 | |
Hypertonicity | increases protein abundance of | COX2 | in MDCK | cytochrome c oxidase subunit II | Favale 2009 | |
Hypertonicity | increases protein abundance of | EGR1 | in MDCK | early growth response 1 | Cohen 1991 | |
Hypertonicity | increases protein abundance of | HSPB1 | in MDCK | heat shock 27kDa protein 1 | Neuhofer 1998 | |
Hypertonicity | increases protein abundance of | HSPA1A | in MDCK | heat shock 70kDa protein 1A | Neuhofer 1998 | |
Hypertonicity | increases protein abundance of | LMNA | in MDCK | lamin A/C | Favale 2007 | |
Hypertonicity | increases protein abundance of | NFAT5 | in MDCK | nuclear factor of activated T-cells 5, tonicity-responsive | Woo 2000 | |
Hypertonicity | increases protein abundance of | STC1 | in MDCK | stanniocalcin 1 | Sheikh-Hamad 2000 | |
Hypertonicity | increases protein abundance of | SOD2 | in MDCK | superoxide dismutase 2, mitochondrial | Zhou 2012 | |
Hypertonicity | increases transcription of | SLC14A1 | in MDCK | solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | Nakayama 2000 | |
Hypertonicity | increases translocation of | LMNA | in MDCK | lamin A/C | Favale 2007 | |
Hypertonicity | increases translocation of | NFAT5 | in MDCK | nuclear factor of activated T-cells 5, tonicity-responsive | Dahl 2001 | |
Hypertonicity | increases translocation of | NFAT5 | in MDCK | nuclear factor of activated T-cells 5, tonicity-responsive | Miyakawa 1999 | |
Hypertonicity | increases translocation of | SLC5A3 | in MDCK | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 | Yamauchi 1993 | |
Hypertonicity | increases translocation of | SLC6A12 | in MDCK | solute carrier family 6 (neurotransmitter transporter), member 12 | Kapus 1999 | |
Hypertonicity | decreases mRNA abundance of | DECR1 | in MEF | 2,4-dienoyl CoA reductase 1, mitochondrial | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | DECR2 | in MEF | 2,4-dienoyl CoA reductase 2, peroxisomal | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | HACL1 | in MEF | 2-hydroxyacyl-CoA lyase 1 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | AKAP7 | in MEF | A kinase (PRKA) anchor protein 7 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ACAT1 | in MEF | acetyl-CoA acetyltransferase 1 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ADHFE1 | in MEF | alcohol dehydrogenase, iron containing, 1 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ALDH6A1 | in MEF | aldehyde dehydrogenase 6 family, member A1 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ATP2B4 | in MEF | ATPase, Ca++ transporting, plasma membrane 4 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ATP9A | in MEF | ATPase, class II, type 9A | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ABCD1 | in MEF | ATP-binding cassette, sub-family D (ALD), member 1 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ACKR3 | in MEF | atypical chemokine receptor 3 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ATG10 | in MEF | autophagy related 10 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | BNIP3 | in MEF | BCL2/adenovirus E1B 19kDa interacting protein 3 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | BRE | in MEF | brain and reproductive organ-expressed (TNFRSF1A modulator) | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | CACNA2D3 | in MEF | calcium channel, voltage-dependent, alpha 2/delta subunit 3 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | CHID1 | in MEF | chitinase domain containing 1 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | CLYBL | in MEF | citrate lyase beta like | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | CIRBP | in MEF | cold inducible RNA binding protein | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | C1RL | in MEF | complement component 1, r subcomponent-like | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | CFB | in MEF | complement factor B | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | CSTAD | in MEF | cystatin A (stefin A) | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | CYP4F13 | in MEF | cytochrome P450, family 4, subfamily f, polypeptide 13 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | DGKG | in MEF | diacylglycerol kinase, gamma 90kDa | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | GM11818 | in MEF | Dsec_GM11818 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ENOX2 | in MEF | ecto-NOX disulfide-thiol exchanger 2 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | EFCAB11 | in MEF | EF-hand calcium binding domain 11 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ECHDC2 | in MEF | enoyl CoA hydratase domain containing 2 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | FAM114A1 | in MEF | family with sequence similarity 114, member A1 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | FAM132A | in MEF | family with sequence similarity 132, member A | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | FERT2 | in MEF | fer (fms/fps related) protein kinase, testis specific 2 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | FGGY | in MEF | FGGY carbohydrate kinase domain containing | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | GPR64 | in MEF | G protein-coupled receptor 64 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | GATSL3 | in MEF | GATS protein-like 3 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | GSTZ1 | in MEF | glutathione S-transferase zeta 1 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | HSPB11 | in MEF | heat shock protein family B (small), member 11 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | HEBP1 | in MEF | heme binding protein 1 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | IFT43 | in MEF | intraflagellar transport 43 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | KNSTRN | in MEF | kinetochore-localized astrin/SPAG5 binding | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | LRBA | in MEF | LPS-responsive vesicle trafficking, beach and anchor containing | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | LOXL4 | in MEF | lysyl oxidase-like 4 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | MEDAG | in MEF | mesenteric estrogen dependent adipogenesis | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | NAALADL2 | in MEF | N-acetylated alpha-linked acidic dipeptidase-like 2 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | NSDHL | in MEF | NAD(P) dependent steroid dehydrogenase-like | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | NPAS3 | in MEF | neuronal PAS domain protein 3 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | NOL3 | in MEF | nucleolar protein 3 (apoptosis repressor with CARD domain) | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | OGDHL | in MEF | oxoglutarate dehydrogenase-like | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | PARD3B | in MEF | par-3 family cell polarity regulator beta | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | PER3 | in MEF | period circadian clock 3 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | PXMP4 | in MEF | peroxisomal membrane protein 4, 24kDa | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | PRPSAP2 | in MEF | phosphoribosyl pyrophosphate synthetase-associated protein 2 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | PHKA2 | in MEF | phosphorylase kinase, alpha 2 (liver) | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | PHYHD1 | in MEF | phytanoyl-CoA dioxygenase domain containing 1 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | GM13375 | in MEF | predicted gene 13375 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | PRKG1 | in MEF | protein kinase, cGMP-dependent, type I | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | PTPLAD2 | in MEF | protein tyrosine phosphatase-like A domain containing 2 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | PDK1 | in MEF | pyruvate dehydrogenase kinase, isozyme 1 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | RRAS | in MEF | related RAS viral (r-ras) oncogene homolog | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ARHGEF10 | in MEF | Rho guanine nucleotide exchange factor (GEF) 10 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | 2210408L21RIK | in MEF | RIKEN cDNA 2210408I21 gene | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | SERF2 | in MEF | small EDRK-rich factor 2 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | SORBS2 | in MEF | sorbin and SH3 domain containing 2 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | SCAPER | in MEF | S-phase cyclin A-associated protein in the ER | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | SCP2 | in MEF | sterol carrier protein 2 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | SYT1 | in MEF | synaptotagmin I | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | SYNC | in MEF | syncoilin, intermediate filament protein | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | TBC1D5 | in MEF | TBC1 domain family, member 5 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | TSPAN17 | in MEF | tetraspanin 17 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | TTC28 | in MEF | tetratricopeptide repeat domain 28 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | TRPV2 | in MEF | transient receptor potential cation channel, subfamily V, member 2 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | TMEM175 | in MEF | transmembrane protein 175 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | TMEM53 | in MEF | transmembrane protein 53 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ZFP125 | in MEF | zinc finger protein 125 | Ortells 2012 | |
Hypertonicity | decreases mRNA abundance of | ZDHHC15 | in MEF | zinc finger, DHHC-type containing 15 | Ortells 2012 | |
Hypertonicity | increases acetylation of | HIST1H4F | in MEF | histone cluster 1, H4f | Ortells 2012 | |
Hypertonicity | increases acetylation of | HIST1H4F | in MEF | histone cluster 1, H4f | Tong 2009 | |
Hypertonicity | increases activity of | MAP3K7 | in MEF | mitogen-activated protein kinase kinase kinase 7 | Inagaki 2008 | |
Hypertonicity | increases activity of | NFAT5 | in MEF | nuclear factor of activated T-cells 5, tonicity-responsive | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | BPGM | in MEF | 2,3-bisphosphoglycerate mutase | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | BDH1 | in MEF | 3-hydroxybutyrate dehydrogenase, type 1 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | AMPD2 | in MEF | adenosine monophosphate deaminase 2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | AMD1 | in MEF | adenosylmethionine decarboxylase 1 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | AKR1B1 | in MEF | aldo-keto reductase family 1, member B1 (aldose reductase) | Lee 2011 | |
Hypertonicity | increases mRNA abundance of | AKR1B3 | in MEF | aldo-keto reductase family 1, member B3 (aldose reductase) | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | AKR1C18 | in MEF | aldo-keto reductase family 1, member C18 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | ANGPT2 | in MEF | angiopoietin 2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | AQP1 | in MEF | aquaporin 1 (Colton blood group) | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | AQP2 | in MEF | aquaporin 2 (collecting duct) | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | ASPN | in MEF | asporin | Lee 2011 | |
Hypertonicity | increases mRNA abundance of | CD24A | in MEF | CD24 molecule | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | CD300LB | in MEF | CD300 molecule-like family member b | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | CD38 | in MEF | CD38 molecule | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | CD79A | in MEF | CD79a molecule, immunoglobulin-associated alpha | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | CD80 | in MEF | CD80 molecule | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | FIGF | in MEF | c-fos induced growth factor (vascular endothelial growth factor D) | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | CCDC3 | in MEF | coiled-coil domain containing 3 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | CRYAB | in MEF | crystallin, alpha B | Lee 2011 | |
Hypertonicity | increases mRNA abundance of | CCNJL | in MEF | cyclin J-like | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | DDIT4 | in MEF | DNA-damage-inducible transcript 4 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | DDIT4L | in MEF | DNA-damage-inducible transcript 4-like | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | DUSP1 | in MEF | dual specificity phosphatase 1 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | DUSP4 | in MEF | dual specificity phosphatase 4 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | DNAHC12 | in MEF | dynein, axonemal, heavy chain 12 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | DKC1 | in MEF | dyskeratosis congenita 1, dyskerin | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | EDA2R | in MEF | ectodysplasin A2 receptor | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | ENPP2 | in MEF | ectonucleotide pyrophosphatase/phosphodiesterase 2 | Lee 2011 | |
Hypertonicity | increases mRNA abundance of | EPHA2 | in MEF | EPH receptor A2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | EPHA7 | in MEF | EPH receptor A7 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | EREG | in MEF | epiregulin | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | ETV1 | in MEF | ets variant 1 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | EEF1G | in MEF | eukaryotic translation elongation factor 1 gamma | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | F11R | in MEF | F11 receptor | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | FAM213A | in MEF | family with sequence similarity 213, member A | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | FOSL1 | in MEF | FOS-like antigen 1 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | GPR81 | in MEF | G protein-coupled receptor 81 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HSPA1A | in MEF | heat shock 70kDa protein 1A | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HSPA1B | in MEF | heat shock 70kDa protein 1B | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HSPA4L | in MEF | heat shock 70kDa protein 4-like | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HIST1H1C | in MEF | histone cluster 1, H1c | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HIST1H1D | in MEF | histone cluster 1, H1d | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HIST1H2AC | in MEF | histone cluster 1, H2ac | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HIST1H2BC | in MEF | histone cluster 1, H2bc | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HIST1H2BG | in MEF | histone cluster 1, H2bg | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HIST1H3D | in MEF | histone cluster 1, H3d | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HIST1H4M | in MEF | histone cluster 1, H4m | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HIST2H2BB | in MEF | histone cluster 2, H2bb (pseudogene) | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HIST2H3C2 | in MEF | histone cluster 2, H3c2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | HIST3H2A | in MEF | histone cluster 3, H2a | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | IGFBP5 | in MEF | insulin-like growth factor binding protein 5 | Lee 2011 | |
Hypertonicity | increases mRNA abundance of | IGFBP7 | in MEF | insulin-like growth factor binding protein 7 | Lee 2011 | |
Hypertonicity | increases mRNA abundance of | ITGA3 | in MEF | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | INA | in MEF | internexin neuronal intermediate filament protein, alpha | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | KBTBD8 | in MEF | kelch repeat and BTB (POZ) domain containing 8 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | KLRG2 | in MEF | killer cell lectin-like receptor subfamily G, member 2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | LAYN | in MEF | layilin | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | LY6C1 | in MEF | lymphocyte antigen 6 complex, locus C1 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | LY6C2 | in MEF | lymphocyte antigen 6 complex, locus C2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | MIA2 | in MEF | melanoma inhibitory activity 2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | MRPS6 | in MEF | mitochondrial ribosomal protein S6 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | MAP2K6 | in MEF | mitogen-activated protein kinase kinase 6 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | MYCT1 | in MEF | myc target 1 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | MTMR10 | in MEF | myotubularin related protein 10 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | NPR1 | in MEF | natriuretic peptide receptor 1 | Lee 2011 | |
Hypertonicity | increases mRNA abundance of | NPY4R | in MEF | neuropeptide Y receptor Y4 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | NRP1 | in MEF | neuropilin 1 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | NUP210L | in MEF | nucleoporin 210kDa-like | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | PLXNA2 | in MEF | plexin A2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | KCNJ1 | in MEF | potassium inwardly-rectifying channel, subfamily J, member 1 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | KCNJ16 | in MEF | potassium inwardly-rectifying channel, subfamily J, member 16 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | GM10047 | in MEF | predicted gene 10047 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | GM10679 | in MEF | predicted gene 10679 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | GM3994 | in MEF | predicted gene 3994 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | GM4975 | in MEF | predicted gene 4975 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | GM7682 | in MEF | predicted gene 7682 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | PRL2C3 | in MEF | prolactin family 2, subfamily c, member 3 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | PRL2C5 | in MEF | prolactin family 2, subfamily c, member 5 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | PRRG4 | in MEF | proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | PTPN22 | in MEF | protein tyrosine phosphatase, non-receptor type 22 (lymphoid | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | RPP25 | in MEF | ribonuclease P/MRP 25kDa subunit | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | 1810011O10RIK | in MEF | RIKEN cDNA 1810011O10 gene | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | 2900052L18RIK | in MEF | RIKEN cDNA 2900052L18 gene | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | 4833403I15RIK | in MEF | RIKEN cDNA 4833403I15 gene | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | 4930572J05RIK | in MEF | RIKEN cDNA 4930572J05 gene | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | A630033H20RIK | in MEF | RIKEN cDNA A630033H20 gene | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | D630023F18RIK | in MEF | RIKEN cDNA D630023F18 gene | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | S100A3 | in MEF | S100 calcium binding protein A3 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SERPINB2 | in MEF | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SH3BGRL2 | in MEF | SH3 domain binding glutamate-rich protein like 2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SIPA1L2 | in MEF | signal-induced proliferation-associated 1 like 2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SNORD116 | in MEF | small nucleolar RNA, C/D box 116-1 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SNORA34 | in MEF | small nucleolar RNA, H/ACA box 34 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SPRR1A | in MEF | small proline-rich protein 1A | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SLC1A3 | in MEF | solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SLC14A1 | in MEF | solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SLC19A2 | in MEF | solute carrier family 19 (thiamine transporter), member 2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | GDC | in MEF | solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SLC39A10 | in MEF | solute carrier family 39 (zinc transporter), member 10 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SLC5A3 | in MEF | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 | Lee 2011 | |
Hypertonicity | increases mRNA abundance of | SLC5A3 | in MEF | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SLC6A12 | in MEF | solute carrier family 6 (neurotransmitter transporter), member 12 | Lee 2011 | |
Hypertonicity | increases mRNA abundance of | SLC6A12 | in MEF | solute carrier family 6 (neurotransmitter transporter), member 12 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SLC6A9 | in MEF | solute carrier family 6 (neurotransmitter transporter), member 9 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | SOX9 | in MEF | SRY (sex determining region Y)-box 9 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | TTC9 | in MEF | tetratricopeptide repeat domain 9 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | TLCD2 | in MEF | TLC domain containing 2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | TMEM171 | in MEF | transmembrane protein 171 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | TMEFF2 | in MEF | transmembrane protein with EGF-like and two follistatin-like domains 2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | TNFRSF21 | in MEF | tumor necrosis factor receptor superfamily, member 21 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | TNFRSF22 | in MEF | tumor necrosis factor receptor superfamily, member 22 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | TNFRSF23 | in MEF | tumor necrosis factor receptor superfamily, member 23 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | TACSTD2 | in MEF | tumor-associated calcium signal transducer 2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | TWIST2 | in MEF | twist family bHLH transcription factor 2 | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | ZSCAN4C | in MEF | zinc finger and SCAN domain containing 4C | Ortells 2012 | |
Hypertonicity | increases mRNA abundance of | ZKSCAN16 | in MEF | zinc finger with KRAB and SCAN domains 16 | Ortells 2012 | |
Hypertonicity | increases protein abundance of | AKR1B1 | in MEF | aldo-keto reductase family 1, member B1 (aldose reductase) | Lee 2011 | |
Hypertonicity | increases protein abundance of | CRYAB | in MEF | crystallin, alpha B | Lee 2011 | |
Hypertonicity | increases protein abundance of | CDO1 | in MEF | cysteine dioxygenase type 1 | Lee 2011 | |
Hypertonicity | increases protein abundance of | ENPP2 | in MEF | ectonucleotide pyrophosphatase/phosphodiesterase 2 | Lee 2011 | |
Hypertonicity | increases protein abundance of | HSPA4 | in MEF | heat shock 70 kDa protein 4 | Lee 2011 | |
Hypertonicity | increases protein abundance of | IGFBP5 | in MEF | insulin-like growth factor binding protein 5 | Lee 2011 | |
Hypertonicity | increases protein abundance of | IGFBP7 | in MEF | insulin-like growth factor binding protein 7 | Lee 2011 | |
Hypertonicity | increases protein abundance of | NPR1 | in MEF | natriuretic peptide receptor 1 | Lee 2011 | |
Hypertonicity | increases protein abundance of | NFAT5 | in MEF | nuclear factor of activated T-cells 5, tonicity-responsive | Lee 2011 | |
Hypertonicity | increases protein abundance of | NFAT5 | in MEF | nuclear factor of activated T-cells 5, tonicity-responsive | Ortells 2012 | |
Hypertonicity | increases protein abundance of | MYL9 | in mesangial | myosin light chain 9 | Takeda 1993 | |
Hypertonicity | increases activity of | NFAT5 | in Met5A | nuclear factor of activated T-cells 5, tonicity-responsive | Kuper 2012 | |
Hypertonicity | increases activity of | NFKB1 | in Met5A | nuclear factor related to kappaB binding protein | Kuper 2012 | |
Hypertonicity | increases mRNA abundance of | CCL2 | in Met5A | chemokine (C-C motif) ligand 2 | Kuper 2012 | |
Hypertonicity | increases mRNA abundance of | NFAT5 | in Met5A | nuclear factor of activated T-cells 5, tonicity-responsive | Kuper 2012 | |
Hypertonicity | increases phosphorylation of | RELA | in Met5A | v-rel avian reticuloendotheliosis viral oncogene homolog A | Kuper 2012 | |
Hypertonicity | increases protein abundance of | CCL2 | in Met5A | chemokine (C-C motif) ligand 2 | Kuper 2012 | |
Hypertonicity | increases protein abundance of | NFAT5 | in Met5A | nuclear factor of activated T-cells 5, tonicity-responsive | Kuper 2012 | |
Hypertonicity | decreases activity of | CDK1 | in mIMCD3 | cyclin-dependent kinase 1 | Dmitrieva 2002 | |
Hypertonicity | decreases protein abundance of | BCL2 | in mIMCD3 | B-cell CLL/lymphoma 2 | Lee 2012 | |
Hypertonicity | decreases protein abundance of | PSME1 | in mIMCD3 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) | Klawitter 2008 | |
Hypertonicity | decreases protein abundance of | UBC | in mIMCD3 | ubiquitin C | Klawitter 2008 | |
Hypertonicity | decreases protein abundance of | UBE2I | in mIMCD3 | ubiquitin-conjugating enzyme E2I | Klawitter 2008 | |
Hypertonicity | increases activity of | ATP1A1 | in mIMCD3 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Capasso 2001 | |
Hypertonicity | increases activity of | ATP1B1 | in mIMCD3 | ATPase, Na+/K+ transporting, beta 1 polypeptide | Capasso 2001 | |
Hypertonicity | increases activity of | MAPK1 | in mIMCD3 | mitogen-activated protein kinase 1 | Berl 1997 | |
Hypertonicity | increases activity of | MAPK14 | in mIMCD3 | mitogen-activated protein kinase 14 | Dmitrieva 2002 | |
Hypertonicity | increases activity of | MAPK14 | in mIMCD3 | mitogen-activated protein kinase 14 | Berl 1997 | |
Hypertonicity | increases activity of | MAPK3 | in mIMCD3 | mitogen-activated protein kinase 3 | Berl 1997 | |
Hypertonicity | increases activity of | MAPK8 | in mIMCD3 | mitogen-activated protein kinase 8 | Berl 1997 | |
Hypertonicity | increases activity of | MPDZ | in mIMCD3 | multiple PDZ domain protein | Lanaspa 2007 | |
Hypertonicity | increases activity of | NFAT5 | in mIMCD3 | nuclear factor of activated T-cells 5, tonicity-responsive | Cai 2005 | |
Hypertonicity | increases activity of | PAX2 | in mIMCD3 | paired box 2 | Cai 2005 | |
Hypertonicity | increases activity of | PTGS2 | in mIMCD3 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | Yang 1999 | |
Hypertonicity | increases activity of | PTK2 | in mIMCD3 | protein tyrosine kinase 2 | Zhang 1998 | |
Hypertonicity | increases activity of | PTK2B | in mIMCD3 | protein tyrosine kinase 2 beta | Zhang 1998 | |
Hypertonicity | increases activity of | TP53 | in mIMCD3 | tumor protein p53 | Dmitrieva 2000 | |
Hypertonicity | increases binding of | CLDN4 | in mIMCD3 | claudin-4 | Lanaspa 2008 | |
Hypertonicity | increases binding of | MPDZ | in mIMCD3 | multiple PDZ domain protein | Lanaspa 2008 | |
Hypertonicity | increases mRNA abundance of | AKR1B1 | in mIMCD3 | aldo-keto reductase family 1, member B1 (aldose reductase) | Klawitter 2008 | |
Hypertonicity | increases mRNA abundance of | AKR1B1 | in mIMCD3 | aldo-keto reductase family 1, member B1 (aldose reductase) | Tian 2000 | |
Hypertonicity | increases mRNA abundance of | AQP1 | in mIMCD3 | aquaporin 1 (Colton blood group) | Jeng 1998 | |
Hypertonicity | increases mRNA abundance of | AQP2 | in mIMCD3 | aquaporin 2 (collecting duct) | Lee 2012 | |
Hypertonicity | increases mRNA abundance of | AQP2 | in mIMCD3 | aquaporin 2 (collecting duct) | Lee 2012 | |
Hypertonicity | increases mRNA abundance of | ATP1A1 | in mIMCD3 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Capasso 2001 | |
Hypertonicity | increases mRNA abundance of | CLDN4 | in mIMCD3 | claudin-4 | Lanaspa 2008 | |
Hypertonicity | increases mRNA abundance of | CHUK | in mIMCD3 | conserved helix-loop-helix ubiquitous kinase | Nahm 2002 | |
Hypertonicity | increases mRNA abundance of | CYR61 | in mIMCD3 | cysteine-rich, angiogenic inducer, 61 | Nahm 2002 | |
Hypertonicity | increases mRNA abundance of | DNAJB4 | in mIMCD3 | DnaJ (Hsp40) homolog, subfamily B, member 4 | Nahm 2002 | |
Hypertonicity | increases mRNA abundance of | EPHA2 | in mIMCD3 | EPH receptor A2 | Nahm 2002 | |
Hypertonicity | increases mRNA abundance of | FHL2 | in mIMCD3 | four and a half LIM domains 2 | Nahm 2002 | |
Hypertonicity | increases mRNA abundance of | FXYD2 | in mIMCD3 | FXYD domain containing ion transport regulator 2 | Capasso 2003 | |
Hypertonicity | increases mRNA abundance of | GADD45A | in mIMCD3 | growth arrest and DNA-damage-inducible, alpha | Chakravarty 2002 | |
Hypertonicity | increases mRNA abundance of | GADD45B | in mIMCD3 | growth arrest and DNA-damage-inducible, beta | Chakravarty 2002 | |
Hypertonicity | increases mRNA abundance of | GADD45G | in mIMCD3 | growth arrest and DNA-damage-inducible, gamma | Chakravarty 2002 | |
Hypertonicity | increases mRNA abundance of | HSPA4 | in mIMCD3 | heat shock 70 kDa protein 4 | Santos 1998 | |
Hypertonicity | increases mRNA abundance of | HSPA4L | in mIMCD3 | heat shock 70kDa protein 4-like | Kojima 1996 | |
Hypertonicity | increases mRNA abundance of | HSPA4L | in mIMCD3 | heat shock 70kDa protein 4-like | Santos 1998 | |
Hypertonicity | increases mRNA abundance of | HS3ST1 | in mIMCD3 | heparan sulfate (glucosamine) 3-O-sulfotransferase 1 | Nahm 2002 | |
Hypertonicity | increases mRNA abundance of | MPDZ | in mIMCD3 | multiple PDZ domain protein | Lanaspa 2007 | |
Hypertonicity | increases mRNA abundance of | MLLT4 | in mIMCD3 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | Lanaspa 2007 | |
Hypertonicity | increases mRNA abundance of | NFAT5 | in mIMCD3 | nuclear factor of activated T-cells 5, tonicity-responsive | Lee 2012 | |
Hypertonicity | increases mRNA abundance of | NUP88 | in mIMCD3 | nucleoporin 88kDa | Andres-Hernando 2008 | |
Hypertonicity | increases mRNA abundance of | PAX2 | in mIMCD3 | paired box 2 | Cai 2005 | |
Hypertonicity | increases mRNA abundance of | PAX2 | in mIMCD3 | paired box 2 | Cai 2005 | |
Hypertonicity | increases mRNA abundance of | PAX8 | in mIMCD3 | paired box 8 | Cai 2005 | |
Hypertonicity | increases mRNA abundance of | PNPLA6 | in mIMCD3 | patatin-like phospholipase domain containing 6 | Gallazini 2006 | |
Hypertonicity | increases mRNA abundance of | PLAT | in mIMCD3 | plasminogen activator, tissue | Cai 2005 | |
Hypertonicity | increases mRNA abundance of | PLAUR | in mIMCD3 | plasminogen activator, urokinase receptor | Cai 2005 | |
Hypertonicity | increases mRNA abundance of | PLAGL1 | in mIMCD3 | pleiomorphic adenoma gene-like 1 | Lanaspa 2009 | |
Hypertonicity | increases mRNA abundance of | PTGS2 | in mIMCD3 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | Yang 1999 | |
Hypertonicity | increases mRNA abundance of | PPP1R15A | in mIMCD3 | protein phosphatase 1 regulatory subunit 15A | Nahm 2002 | |
Hypertonicity | increases mRNA abundance of | PTK2 | in mIMCD3 | protein tyrosine kinase 2 | Lunn 2007 | |
Hypertonicity | increases mRNA abundance of | S100A4 | in mIMCD3 | S100 calcium binding protein A4 | Rivard 2007 | |
Hypertonicity | increases mRNA abundance of | SGK1 | in mIMCD3 | serum/glucocorticoid regulated kinase 1 | Lee 2012 | |
Hypertonicity | increases mRNA abundance of | SLC14A2 | in mIMCD3 | solute carrier family 14 (urea transporter), member 2 | Leroy 2000 | |
Hypertonicity | increases mRNA abundance of | SLC2A1 | in mIMCD3 | solute carrier family 2 (facilitated glucose transporter), member 1 | Klawitter 2008 | |
Hypertonicity | increases mRNA abundance of | SLC5A3 | in mIMCD3 | solute carrier family 5 (sodium/myo-inositol cotransporter), member 3 | Lee 2012 | |
Hypertonicity | increases mRNA abundance of | TJP1 | in mIMCD3 | tight junction protein 1 | Lanaspa 2007 | |
Hypertonicity | increases mRNA abundance of | TJP1 | in mIMCD3 | tight junction protein 1 | Then 2011 | |
Hypertonicity | increases mRNA abundance of | TSC22D2 | in mIMCD3 | TSC22 domain family, member 2 | Fiol 2007 | |
Hypertonicity | increases mRNA abundance of | TSC22D3 | in mIMCD3 | TSC22 domain family, member 3 | Fiol 2007 | |
Hypertonicity | increases mRNA abundance of | TSC22D4 | in mIMCD3 | TSC22 domain family, member 4 | Fiol 2007 | |
Hypertonicity | increases mRNA abundance of | ZFP36L1 | in mIMCD3 | ZFP36 ring finger protein-like 1 | Nahm 2002 | |
Hypertonicity | increases mRNA stability of | NFAT5 | in mIMCD3 | nuclear factor of activated T-cells 5, tonicity-responsive | Cai 2005 | |
Hypertonicity | increases mRNA stability of | TSC22D2 | in mIMCD3 | TSC22 domain family, member 2 | Fiol 2007 | |
Hypertonicity | increases phosphorylation of | MAPK14 | at T180/Y182 | in mIMCD3 | mitogen-activated protein kinase 14 | Dmitrieva 2002 |
Hypertonicity | increases phosphorylation of | PTK2 | in mIMCD3 | protein tyrosine kinase 2 | Lunn 2007 | |
Hypertonicity | increases phosphorylation of | PTK2B | in mIMCD3 | protein tyrosine kinase 2 beta | Zhang 1998 | |
Hypertonicity | increases phosphorylation of | SGK1 | in mIMCD3 | serum/glucocorticoid regulated kinase 1 | Lee 2012 | |
Hypertonicity | increases phosphorylation of | TAZ | at Y316 | in mIMCD3 | tafazzin | Jang 2002 |
Hypertonicity | increases phosphorylation of | TJP1 | in mIMCD3 | tight junction protein 1 | Then 2011 | |
Hypertonicity | increases phosphorylation of | TP53 | at S15 | in mIMCD3 | tumor protein p53 | Dmitrieva 2000 |
Hypertonicity | increases protein abundance of | ATF3 | in mIMCD3 | activating transcription factor 3 | Tian 2002 | |
Hypertonicity | increases protein abundance of | AKR1B1 | in mIMCD3 | aldo-keto reductase family 1, member B1 (aldose reductase) | Klawitter 2008 | |
Hypertonicity | increases protein abundance of | ALDOA | in mIMCD3 | aldolase A, fructose-bisphosphate | Klawitter 2008 | |
Hypertonicity | increases protein abundance of | AQP1 | in mIMCD3 | aquaporin 1 (Colton blood group) | Jeng 1998 | |
Hypertonicity | increases protein abundance of | AQP2 | in mIMCD3 | aquaporin 2 (collecting duct) | Lee 2012 | |
Hypertonicity | increases protein abundance of | AQP2 | in mIMCD3 | aquaporin 2 (collecting duct) | Lee 2012 | |
Hypertonicity | increases protein abundance of | ATP1A1 | in mIMCD3 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Capasso 2001 | |
Hypertonicity | increases protein abundance of | ATP1A2 | in mIMCD3 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | Lee 2012 | |
Hypertonicity | increases protein abundance of | ATP1B1 | in mIMCD3 | ATPase, Na+/K+ transporting, beta 1 polypeptide | Capasso 2001 | |
Hypertonicity | increases protein abundance of | BAX | in mIMCD3 | BCL2-associated X protein | Lee 2012 | |
Hypertonicity | increases protein abundance of | CASP3 | in mIMCD3 | caspase 3, apoptosis-related cysteine peptidase | Lee 2012 | |
Hypertonicity | increases protein abundance of | CLDN4 | in mIMCD3 | claudin-4 | Lanaspa 2008 | |
Hypertonicity | increases protein abundance of | ENO1 | in mIMCD3 | enolase 1, (alpha) | Klawitter 2008 | |
Hypertonicity | increases protein abundance of | FXYD2 | in mIMCD3 | FXYD domain containing ion transport regulator 2 | Capasso 2003 | |
Hypertonicity | increases protein abundance of | GRIN3A | in mIMCD3 | glutamate receptor, ionotropic, N-methyl-D-aspartate 3A | Sproul 2011 | |
Hypertonicity | increases protein abundance of | GAPDH | in mIMCD3 | glyceraldehyde-3-phosphate dehydrogenase | Klawitter 2008 | |
Hypertonicity | increases protein abundance of | GADD45A | in mIMCD3 | growth arrest and DNA-damage-inducible, alpha | Chakravarty 2002 | |
Hypertonicity | increases protein abundance of | GADD45B | in mIMCD3 | growth arrest and DNA-damage-inducible, beta | Chakravarty 2002 | |
Hypertonicity | increases protein abundance of | HSPA1A | in mIMCD3 | heat shock 70kDa protein 1A | Rauchman 1997 | |
Hypertonicity | increases protein abundance of | ME1 | in mIMCD3 | malic enzyme 1, NADP(+)-dependent, cytosolic | Klawitter 2008 | |
Hypertonicity | increases protein abundance of | MPDZ | in mIMCD3 | multiple PDZ domain protein | Lanaspa 2007 | |
Hypertonicity | increases protein abundance of | MLLT4 | in mIMCD3 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | Lanaspa 2007 | |
Hypertonicity | increases protein abundance of | NFAT5 | in mIMCD3 | nuclear factor of activated T-cells 5, tonicity-responsive | Cai 2005 | |
Hypertonicity | increases protein abundance of | NUP88 | in mIMCD3 | nucleoporin 88kDa | Andres-Hernando 2008 | |
Hypertonicity | increases protein abundance of | PAX2 | in mIMCD3 | paired box 2 | Cai 2005 | |
Hypertonicity | increases protein abundance of | PNPLA6 | in mIMCD3 | patatin-like phospholipase domain containing 6 | Gallazini 2006 | |
Hypertonicity | increases protein abundance of | PGAM1 | in mIMCD3 | phosphoglycerate mutase 1 (brain) | Klawitter 2008 | |
Hypertonicity | increases protein abundance of | PLAGL1 | in mIMCD3 | pleiomorphic adenoma gene-like 1 | Lanaspa 2009 | |
Hypertonicity | increases protein abundance of | PTGS2 | in mIMCD3 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | Yang 1999 | |
Hypertonicity | increases protein abundance of | PC | in mIMCD3 | pyruvate carboxylase | Klawitter 2008 | |
Hypertonicity | increases protein abundance of | PKLR | in mIMCD3 | pyruvate kinase, liver and RBC | Klawitter 2008 | |
Hypertonicity | increases protein abundance of | S100A4 | in mIMCD3 | S100 calcium binding protein A4 | Rivard 2007 | |
Hypertonicity | increases protein abundance of | TJP1 | in mIMCD3 | tight junction protein 1 | Lanaspa 2007 | |
Hypertonicity | increases protein abundance of | TJP1 | in mIMCD3 | tight junction protein 1 | Then 2011 | |
Hypertonicity | increases protein abundance of | TPI1 | in mIMCD3 | triosephosphate isomerase 1 | Klawitter 2008 | |
Hypertonicity | increases protein abundance of | TP53 | in mIMCD3 | tumor protein p53 | Dmitrieva 2000 | |
Hypertonicity | increases transcription of | PNPLA6 | in mIMCD3 | patatin-like phospholipase domain containing 6 | Gallazini 2006 | |
Hypertonicity | increases translocation of | AQP1 | in mIMCD3 | aquaporin 1 (Colton blood group) | Jeng 1998 | |
Hypertonicity | increases translocation of | AQP2 | in mIMCD3 | aquaporin 2 (collecting duct) | Lee 2012 | |
Hypertonicity | increases translocation of | AQP2 | in mIMCD3 | aquaporin 2 (collecting duct) | Lee 2012 | |
Hypertonicity | increases translocation of | CLDN4 | in mIMCD3 | claudin-4 | Lanaspa 2008 | |
Hypertonicity | increases translocation of | MRE11A | in mIMCD3 | MRE11 meiotic recombination 11 homolog A (S. cerevisiae) | Dmitrieva 2003 | |
Hypertonicity | decreases mRNA abundance of | SLC9A1 | in miMICD3 | solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 | Soleimani 1994 | |
Hypertonicity | increases activity of | SLC9A2 | in miMICD3 | solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 | Soleimani 1994 | |
Hypertonicity | increases mRNA abundance of | SLC9A2 | in miMICD3 | solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 | Soleimani 1994 | |
Hypertonicity | increases binding of | NRG1 | in MLE-12 | neuregulin 1 | Herrlich 2004 | |
Hypertonicity | increases binding of | PIK3R1 | in MLE-12 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Herrlich 2004 | |
Hypertonicity | increases binding of | SHC1 | in MLE-12 | SHC (Src homology 2 domain containing) transforming protein 1 | Herrlich 2004 | |
Hypertonicity | increases cleavage of | NRG1 | in MLE-12 | neuregulin 1 | Herrlich 2004 | |
Hypertonicity | increases phosphorylation of | MAPK1 | in MLE-12 | mitogen-activated protein kinase 1 | Herrlich 2004 | |
Hypertonicity | increases phosphorylation of | MAPK3 | in MLE-12 | mitogen-activated protein kinase 3 | Herrlich 2004 | |
Hypertonicity | increases phosphorylation of | ERBB2 | in MLE-12 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Herrlich 2004 | |
Hypertonicity | increases phosphorylation of | ERBB3 | in MLE-12 | v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 3 | Herrlich 2004 | |
Hypertonicity | increases protein abundance of | AQP5 | in MLE-12 | aquaporin 5 | Herrlich 2004 | |
Hypertonicity | increases mRNA abundance of | AQP5 | in MLE-15 | aquaporin 5 | Hoffert 2000 | |
Hypertonicity | increases mRNA abundance of | HIF1A | in MLE-15 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Zhou 2007 | |
Hypertonicity | increases protein abundance of | AQP5 | in MLE-15 | aquaporin 5 | Hoffert 2000 | |
Hypertonicity | increases protein abundance of | ATP1A1 | in mouse kidney papilla | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Capasso 2001 | |
Hypertonicity | increases protein abundance of | AQP2 | in mpkCCD | aquaporin 2 (collecting duct) | Hasler 2005 | |
Hypertonicity | increases transcription of | AQP2 | in mpkCCD | aquaporin 2 (collecting duct) | Hasler 2005 | |
Hypertonicity | increases activity of | EIF2AK3 | in mpkCCDc14 | eukaryotic translation initiation factor 2-alpha kinase 3 precursor | Crambert 2014 | |
Hypertonicity | increases activity of | ATF6 | in mpkCCDc14 | cyclic AMP-dependent transcription factor ATF-6 alpha | Crambert 2014 | |
Hypertonicity | increases activty of | NFAT5 | in mpkCCDc14 | nuclear factor of activated T-cells 5, tonicity-responsive | Hasler 2006 | |
Hypertonicity | increases binding of | NFATC1 | in mpkCCDc14 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | Li 2007 | |
Hypertonicity | increases mRNA abundance of | NFAT5 | in mpkCCDc14 | nuclear factor of activated T-cells 5, tonicity-responsive | Hasler 2006 | |
Hypertonicity | increases mRNA abundance of | ATF6 | in mpkCCDc14 | cyclic AMP-dependent transcription factor ATF-6 alpha | Crambert 2014 | |
Hypertonicity | increases phosphorylation of | EIF2AK3 | in mpkCCDc14 | eukaryotic translation initiation factor 2-alpha kinase 3 precursor | Crambert 2014 | |
Hypertonicity | increases protein abundance of | NFAT5 | in mpkCCDc14 | nuclear factor of activated T-cells 5, tonicity-responsive | Hasler 2006 | |
Hypertonicity | increases protein abundance of | AQP2 | in mpkCCDc14 | aquaporin-2 | Crambert 2014 | |
Hypertonicity | increases protein abundance of | SCNN1A | in mpkCCDc14 | amiloride-sensitive sodium channel subunit alpha | Crambert 2014 | |
Hypertonicity | increases protein abundance of | SCNN1B | in mpkCCDc14 | amiloride-sensitive sodium channel subunit beta | Crambert 2014 | |
Hypertonicity | increases protein abundance of | SCNN1G | in mpkCCDc14 | amiloride-sensitive sodium channel subunit gamma | Crambert 2014 | |
Hypertonicity | increases translocation of | NFATC1 | in mpkCCDc14 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | Li 2007 | |
Hypertonicity | increases mRNA abundance of | KCNJ1 | in MTAL | potassium inwardly-rectifying channel, subfamily J, member 1 | Gallazzini 2003 | |
Hypertonicity | increases mRNA abundance of | SLC12A1 | in mTAL | solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Hao 2011 | |
Hypertonicity | increases mRNA abundance of | SLC12A1 | in mTAL | solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Hao 2013 | |
Hypertonicity | increases mRNA abundance of | PTGS2 | in mTAL | prostaglandin G/H synthase 2 precursor | Hao 2014 | |
Hypertonicity | increases mRNA abundance of | PTGER3 | in mTAL | Prostaglandin E Receptor 3 (Subtype EP3) | Hao 2014 | |
Hypertonicity | increases protein abundance of | KCNJ1 | in MTAL | potassium inwardly-rectifying channel, subfamily J, member 1 | Gallazzini 2003 | |
Hypertonicity | increases protein abundance of | SLC12A1 | in mTAL | solute carrier family 12 (sodium/potassium/chloride transporter), member 1 | Hao 2011 | |
Hypertonicity | increases protein abundance of | PTGS2 | in mTAL | prostaglandin G/H synthase 2 precursor | Hao 2014 | |
Hypertonicity | increases protein abundance of | PTGER3 | in mTAL | Prostaglandin E Receptor 3 (Subtype EP3) | Hao 2014 | |
Hypertonicity | increases translocation of | ACTG1 | in MTAL native | actin, gamma 1 | Bustamante 2003 | |
Hypertonicity | increases translocation of | APBB1 | in Neuro2a | amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) | Nakaya 2008 | |
Hypertonicity | increases translocation of | NFAT5 | in neurons | nuclear factor of activated T-cells 5, tonicity-responsive | Loyher 2004 | |
Hypertonicity | increases activity of | CDC42 | in neutrophils | cell division cycle 42 | Lewis 2002 | |
Hypertonicity | increases activity of | FGR | in neutrophils | feline Gardner-Rasheed sarcoma viral oncogene homolog | Krump 1997 | |
Hypertonicity | increases activity of | HCK | in neutrophils | hemopoietic cell kinase | Krump 1997 | |
Hypertonicity | increases activity of | MAPK14 | in neutrophils | mitogen-activated protein kinase 14 | Rizoli 1999 | |
Hypertonicity | increases activity of | SLC9A1 | in neutrophils | solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 | Krump 1997 | |
Hypertonicity | increases phosphorylation of | HCK | in neutrophils | hemopoietic cell kinase | Krump 1997 | |
Hypertonicity | increases phosphorylation of | MAPK14 | in neutrophils | mitogen-activated protein kinase 14 | Rizoli 1999 | |
Hypertonicity | increases phosphorylation of | FGR | in neutrophils | feline Gardner-Rasheed sarcoma viral oncogene homolog | Krump 1997 | |
Hypertonicity | increases shedding of | PTK2B | in neutrophils | protein tyrosine kinase 2 beta | Rizoli 1999 | |
Hypertonicity | increases shedding of | SELL | in neutrophils | selectin L | Rizoli 1999 | |
Hypertonicity | increases shedding of | SYK | in neutrophils | spleen tyrosine kinase | Rizoli 1999 | |
Hypertonicity | increases translocation of | CDC42 | in neutrophils | cell division cycle 42 | Lewis 2002 | |
Hypertonicity | increases transcription of | TERT | in NIH3T3 | telomerase reverse transcriptase | Fujiki 2010 | |
Hypertonicity | increases activity of | SGK1 | in NMuMg | serum/glucocorticoid regulated kinase 1 | Bell 2000 | |
Hypertonicity | increases mRNA abundance of | SGK1 | in NMuMg | serum/glucocorticoid regulated kinase 1 | Bell 2000 | |
Hypertonicity | increases protein abundance of | SGK1 | in NMuMg | serum/glucocorticoid regulated kinase 1 | Bell 2000 | |
Hypertonicity | increases transcription of | SGK1 | in NMuMg | serum/glucocorticoid regulated kinase 1 | Bell 2000 | |
Hypertonicity | increases translocation of | SGK1 | in NMuMg | serum/glucocorticoid regulated kinase 1 | Bell 2000 | |
Hypertonicity | increases activity of | TGFB1 | in NRK | transforming growth factor, beta 1 | Suquira 1998 | |
Hypertonicity | increases mRNA abundance of | CCL2 | in NRK52E | chemokine (C-C motif) ligand 2 | Kojima 2010 | |
Hypertonicity | increases protein abundance of | CCL2 | in NRK52E | chemokine (C-C motif) ligand 2 | Kojima 2010 | |
Hypertonicity | increases activity of | EPHB1 | in nucleus pulposus | EPH receptor B1 | Tsai 2007 | |
Hypertonicity | increases mRNA abundance of | AQP2 | in nucleus pulposus | aquaporin 2 (collecting duct) | Gajghate 2009 | |
Hypertonicity | increases phosphorylation of | EPHB1 | in nucleus pulposus | EPH receptor B1 | Tsai 2007 | |
Hypertonicity | increases activity of | SLC9A3 | in OKP | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Ambuhl 1998 | |
Hypertonicity | increases mRNA abundance of | SLC9A3 | in OKP | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Ambuhl 1998 | |
Hypertonicity | increases protein abundance of | SLC9A3 | in OKP | solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 | Ambuhl 1998 | |
Hypertonicity | increases mRNA abundance of | NFAT5 | in OM | nuclear factor of activated T-cells 5, tonicity-responsive | Hao 2013 | |
Hypertonicity | increases mRNA abundance of | STC1 | in OM | stanniocalcin 1 | Turner 2010 | |
Hypertonicity | increases protein abundance of | NFAT5 | in OM | nuclear factor of activated T-cells 5, tonicity-responsive | Hao 2013 | |
Hypertonicity | increases mRNA abundance of | SLC12A2 | in OMCD | solute carrier family 12 (sodium/potassium/chloride transporter), member 2 | Wakamatsu 2009 | |
Hypertonicity | decreases mRNA abundance of | ACTB | in p2mIME | actin, beta | Cai 2004 | |
Hypertonicity | increases mRNA abundance of | AKR1B1 | in p2mIME | aldo-keto reductase family 1, member B1 (aldose reductase) | Cai 2004 | |
Hypertonicity | increases mRNA abundance of | GADD45A | in p2mIME | growth arrest and DNA-damage-inducible, alpha | Chakravarty 2002 | |
Hypertonicity | increases mRNA abundance of | GADD45B | in p2mIME | growth arrest and DNA-damage-inducible, beta | Chakravarty 2002 | |
Hypertonicity | increases mRNA abundance of | GADD45G | in p2mIME | growth arrest and DNA-damage-inducible, gamma | Chakravarty 2002 | |
Hypertonicity | increases mRNA abundance of | HSPA1A | in p2mIME | heat shock 70kDa protein 1A | Cai 2004 | |
Hypertonicity | increases mRNA abundance of | HSPA2 | in p2mIME | heat shock 70kDa protein 2 | Cai 2004 | |
Hypertonicity | increases mRNA abundance of | HSPA4L | in p2mIME | heat shock 70kDa protein 4-like | Cai 2004 | |
Hypertonicity | increases mRNA abundance of | SLC6A12 | in p2mIME | solute carrier family 6 (neurotransmitter transporter), member 12 | Cai 2004 | |
Hypertonicity | increases activity of | AKR1B1 | in PAP-HT25 | aldo-keto reductase family 1, member B1 (aldose reductase) | Bedford 1987 | |
Hypertonicity | increases mRNA abundance of | AKR1B1 | in PAP-HT25 | aldo-keto reductase family 1, member B1 (aldose reductase) | Smardo 1998 | |
Hypertonicity | increases mRNA abundance of | CD9 | in PAP-HT25 | CD9 molecule | Shiekh-Hamad 1996 | |
Hypertonicity | increases phosphorylation of | JUN | at S73 | in PAP-HT25 | jun proto-oncogene | Kultz 1997 |
Hypertonicity | increases phosphorylation of | MAPK14 | at Y182 | in PAP-HT25 | mitogen-activated protein kinase 14 | Kultz 1997 |
Hypertonicity | increases protein abundance of | AKR1B1 | in PAP-HT25 | aldo-keto reductase family 1, member B1 (aldose reductase) | Bedford 1987 | |
Hypertonicity | increases transcription of | AKR1B1 | in PAP-HT25 | aldo-keto reductase family 1, member B1 (aldose reductase) | Ferraris 1994 | |
Hypertonicity | increases transcription of | AKR1B1 | in PAP-HT25 | aldo-keto reductase family 1, member B1 (aldose reductase) | Smardo 1998 | |
Hypertonicity | increases mRNA abundance of | IL1A | in PBMC | interleukin 1, alpha | Shapiro 1997 | |
Hypertonicity | increases mRNA abundance of | IL1B | in PBMC | interleukin 1, beta | Shapiro 1997 | |
Hypertonicity | increases mRNA abundance of | IL8 | in PBMC | interleukin 8 | Shapiro 1997 | |
Hypertonicity | increases protein abundance of | IL1B | in PBMC | interleukin 1, beta | Shapiro 1997 | |
Hypertonicity | increases protein abundance of | IL8 | in PBMC | interleukin 8 | Shapiro 1997 | |
Hypertonicity | increases activity of | MAPK8 | in PC12 | mitogen-activated protein kinase 8 | Matsuda 1995 | |
Hypertonicity | increases activity of | MAPK9 | in PC12 | mitogen-activated protein kinase 9 | Matsuda 1995 | |
Hypertonicity | increases activity of | MAP3K1 | in PC12 | mitogen-activated protein kinase kinase kinase 1 | Matsuda 1995 | |
Hypertonicity | increases activity of | RAF1 | in PC12 | v-raf-1 murine leukemia viral oncogene homolog 1 | Matsuda 1995 | |
Hypertonicity | increases phosphorylation of | STMN1 | at S38 and S63 | in PC12 | stathmin 1 | Yip 2013 |
Hypertonicity | increases mRNA abundance of | AQP4 | in rat brain cortex | aquaporin 4 | Arima 2003 | |
Hypertonicity | increases mRNA abundance of | AQP9 | in rat brain cortex | aquaporin 9 | Arima 2003 | |
Hypertonicity | increases protein abundance of | AQP4 | in rat brain cortex | aquaporin 4 | Arima 2003 | |
Hypertonicity | increases protein abundance of | AQP9 | in rat brain cortex | aquaporin 9 | Arima 2003 | |
Hypertonicity | increases mRNA abundance of | NFAT5 | in renal medulla | nuclear factor of activated T-cells 5, tonicity-responsive | Sheen 2009 | |
Hypertonicity | increases protein abundance of | NFAT5 | in renal medulla | nuclear factor of activated T-cells 5, tonicity-responsive | Sheen 2009 | |
Hypertonicity | decreases binding of | AGTR1 | in RMIC | angiotensin II receptor, type 1 | Mairc 2001 | |
Hypertonicity | decreases mRNA abundance of | AGTR1 | in RMIC | angiotensin II receptor, type 1 | Sunghou 2005 | |
Hypertonicity | decreases phosphorylation of | GSK3B | in RMIC | glycogen synthase kinase 3 beta | Roa 2004 | |
Hypertonicity | decreases phosphorylation of | PRKAA1 | in RMIC | protein kinase, AMP-activated, alpha 1 catalytic subunit | Han 2011 | |
Hypertonicity | increases activity of | GSK3B | in RMIC | glycogen synthase kinase 3 beta | Roa 2004 | |
Hypertonicity | increases activity of | PPARD | in RMIC | peroxisome proliferator-activated receptor delta | Hao 2002 | |
Hypertonicity | increases activity of | PTGS2 | in RMIC | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | Han 2011 | |
Hypertonicity | increases translocation of | NFKB1 | in RMIC | nuclear factor related to kappaB binding protein | Han 2011 | |
Hypertonicity | increases mRNA abundance of | LYVE1 | in skin cells | lymphatic vessel endothelial hyaluronan receptor 1 | Wiig 2013 | |
Hypertonicity | increases mRNA abundance of | NOS3 | in skin cells | nitric oxide synthase 3 (endothelial cell) | Wiig 2013 | |
Hypertonicity | increases mRNA abundance of | NFAT5 | in skin cells | nuclear factor of activated T-cells 5, tonicity-responsive | Wiig 2013 | |
Hypertonicity | increases mRNA abundance of | VEGFC | in skin cells | vascular endothelial growth factor C | Wiig 2013 | |
Hypertonicity | increases phosphorylation of | NOS3 | in skin cells | nitric oxide synthase 3 (endothelial cell) | Wiig 2013 | |
Hypertonicity | increases phosphorylation of | NOS3 | in skin cells | nitric oxide synthase 3 (endothelial cell) | Wiig 2013 | |
Hypertonicity | increases protein abundance of | NOS3 | in skin cells | nitric oxide synthase 3 (endothelial cell) | Wiig 2013 | |
Hypertonicity | increases protein abundance of | VEGFC | in skin cells | vascular endothelial growth factor C | Wiig 2013 | |
Hypertonicity | increases activity of | NFAT5 | in SMC | nuclear factor of activated T-cells 5, tonicity-responsive | Halterman 2011 | |
Hypertonicity | increases protein abundance of | MYL9 | in SMC | myosin light chain 9 | Klein 1995 | |
Hypertonicity | increases protein abundance of | NFAT5 | in SMC | nuclear factor of activated T-cells 5, tonicity-responsive | Halterman 2011 | |
Hypertonicity | increases binding of | AKAP13 | in splenocytes | A kinase (PRKA) anchor protein 13 | Kino 2009 | |
Hypertonicity | increases binding of | SPAG9 | in splenocytes | sperm associated antigen 9 | Kino 2009 | |
Hypertonicity | increases mRNA abundance of | TNFSF13B | in splenocytes | tumor necrosis factor (ligand) superfamily, member 13b | Kino 2009 | |
Hypertonicity | increases protein abundance of | TNFSF13B | in splenocytes | tumor necrosis factor (ligand) superfamily, member 13b | Kino 2009 | |
Hypertonicity | increases protein abundance of | AQP5 | in submandibular gland | aquaporin 5 | Hoffert 2000 | |
Hypertonicity | decreases phosphorylation of | GSK3B | at S6 | in SW-13 | glycogen synthase kinase 3 beta | Perez-Pinera 2006 |
Hypertonicity | increases mRNA abundance of | MVP | in SW620 | major vault protein | Ikeda 2008 | |
Hypertonicity | increases phosphorylation of | AKT1 | in SW620 | v-akt murine thymoma viral oncogene homolog 1 | Ikeda 2008 | |
Hypertonicity | increases protein abundance of | MVP | in SW620 | major vault protein | Ikeda 2008 | |
Hypertonicity | increases transcription of | MVP | in SW620 | major vault protein | Ikeda 2008 | |
Hypertonicity | increases mRNA abundance of | CD24 | in T lymphocyte | CD24 molecule | Berga-Bolanos 2010 | |
Hypertonicity | increases protein abundance of | CD24 | in T lymphocyte | CD24 molecule | Berga-Bolanos 2010 | |
Hypertonicity | decreases protein abundance of | PDIA2 | in TAHL | protein disulfide isomerase family A, member 2 | Dihazi 2005 | |
Hypertonicity | increases mRNA abundance of | KRT1 | in TAHL | keratin 1 | Dihazi 2005 | |
Hypertonicity | increases protein abundance of | KRT1 | in TAHL | keratin 1 | Dihazi 2005 | |
Hypertonicity | increases protein abundance of | TPM4 | in TAHL | tropomyosin 4 | Dihazi 2005 | |
Hypertonicity | increases protein abundance of | VIM | in TAHL | vimentin | Dihazi 2005 | |
Hypertonicity | decreases protein abundance of | CALR | in TALH | calreticulin | Dihazi 2005 | |
Hypertonicity | decreases protein abundance of | HSPA5 | in TALH | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | Dihazi 2005 | |
Hypertonicity | increases protein abundance of | HSP90AA1 | in TALH | heat shock protein 90kDa alpha (cytosolic), class A member 1 | Dihazi 2005 | |
Hypertonicity | decreases mRNA abundance of | CD27 | in TH17 | CD27 molecule | Kleinewietfeld 2013 | |
Hypertonicity | decreases mRNA abundance of | CD58 | in TH17 | CD58 molecule | Kleinewietfeld 2013 | |
Hypertonicity | decreases mRNA abundance of | CXCL10 | in TH17 | chemokine (C-X-C motif) ligand 10 | Kleinewietfeld 2013 | |
Hypertonicity | decreases mRNA abundance of | CXCL13 | in TH17 | chemokine (C-X-C motif) ligand 13 | Kleinewietfeld 2013 | |
Hypertonicity | decreases mRNA abundance of | CXCR6 | in TH17 | chemokine (C-X-C motif) receptor 6 | Kleinewietfeld 2013 | |
Hypertonicity | decreases mRNA abundance of | GATA3 | in TH17 | GATA binding protein 3 | Kleinewietfeld 2013 | |
Hypertonicity | decreases mRNA abundance of | GZMA | in TH17 | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | Kleinewietfeld 2013 | |
Hypertonicity | decreases mRNA abundance of | GZMK | in TH17 | granzyme K (granzyme 3; tryptase II) | Kleinewietfeld 2013 | |
Hypertonicity | decreases mRNA abundance of | IKZF1 | in TH17 | IKAROS family zinc finger 1 (Ikaros) | Kleinewietfeld 2013 | |
Hypertonicity | decreases mRNA abundance of | PIK3IP1 | in TH17 | phosphoinositide-3-kinase interacting protein 1 | Kleinewietfeld 2013 | |
Hypertonicity | decreases mRNA abundance of | RUNX2 | in TH17 | runt-related transcription factor 2 | Kleinewietfeld 2013 | |
Hypertonicity | decreases mRNA abundance of | SELL | in TH17 | selectin L | Kleinewietfeld 2013 | |
Hypertonicity | decreases mRNA abundance of | SMAD3 | in TH17 | SMAD family member 3 | Kleinewietfeld 2013 | |
Hypertonicity | increases mRNA abundance of | CCL20 | in TH17 | chemokine (C-C motif) ligand 20 | Kleinewietfeld 2013 | |
Hypertonicity | increases mRNA abundance of | CCR6 | in TH17 | chemokine (C-C motif) receptor 6 | Kleinewietfeld 2013 | |
Hypertonicity | increases mRNA abundance of | CSF2 | in TH17 | colony stimulating factor 2 (granulocyte-macrophage) | Kleinewietfeld 2013 | |
Hypertonicity | increases mRNA abundance of | IL17A | in TH17 | interleukin 17A | Kleinewietfeld 2013 | |
Hypertonicity | increases mRNA abundance of | IL17F | in TH17 | interleukin 17F | Kleinewietfeld 2013 | |
Hypertonicity | increases mRNA abundance of | IL2 | in TH17 | interleukin 2 | Kleinewietfeld 2013 | |
Hypertonicity | increases mRNA abundance of | IL23R | in TH17 | interleukin 23 receptor | Kleinewietfeld 2013 | |
Hypertonicity | increases mRNA abundance of | RORA | in TH17 | RAR-related orphan receptor A | Kleinewietfeld 2013 | |
Hypertonicity | increases mRNA abundance of | RORC | in TH17 | RAR-related orphan receptor C | Kleinewietfeld 2013 | |
Hypertonicity | increases mRNA abundance of | RUNX1 | in TH17 | runt-related transcription factor 1 | Kleinewietfeld 2013 | |
Hypertonicity | increases mRNA abundance of | SGK1 | in TH17 | serum/glucocorticoid regulated kinase 1 | Kleinewietfeld 2013 | |
Hypertonicity | increases mRNA abundance of | TNF | in TH17 | tumor necrosis factor | Kleinewietfeld 2013 | |
Hypertonicity | increases phosphorylation of | SELL | in TH17 | selectin L | Kleinewietfeld 2013 | |
Hypertonicity | increases phosphorylation of | NFAT5 | in Th1-D5 | nuclear factor of activated T-cells 5, tonicity-responsive | Lopez-Rodriguez 2001 | |
Hypertonicity | increases protein abundance of | NFAT5 | in Th1-D5 | nuclear factor of activated T-cells 5, tonicity-responsive | Lopez-Rodriguez 2001 | |
Hypertonicity | increases translocation of | NFAT5 | in Th1-D5 | nuclear factor of activated T-cells 5, tonicity-responsive | Lopez-Rodriguez 2001 | |
Hypertonicity | increases activity of | SLC9A1 | in thymocytes | solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 | Grinstein 1985 | |
Hypertonicity | increases activity of | RHOD | in T-REx 293 | ras homolog family member D | Di Ciano-Olviera 2003 | |
Hypertonicity | increases mRNA abundance of | ADM | in T-REx 293 | adrenomedullin | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | ANKRD10 | in T-REx 293 | ankyrin repeat domain 10 | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | CITED2 | in T-REx 293 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | CDCA4 | in T-REx 293 | cell division cycle associated 4 | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | CXCR4 | in T-REx 293 | chemokine (C-X-C motif) receptor 4 | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | CTGF | in T-REx 293 | connective tissue growth factor | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | EGR3 | in T-REx 293 | early growth response 3 | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | IER3 | in T-REx 293 | immediate early response 3 | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | MED26 | in T-REx 293 | mediator complex subunit 26 | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | PLK2 | in T-REx 293 | polo-like kinase 2 | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | SGK1 | in T-REx 293 | serum/glucocorticoid regulated kinase 1 | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | SNAI1 | in T-REx 293 | snail family zinc finger 1 | Huang 2005 | |
Hypertonicity | increases mRNA abundance of | THBS1 | in T-REx 293 | thrombospondin 1 | Huang 2005 | |
Hypertonicity | increases translocation of | NCL | in U2-OS | nucleolin | Yang 2008 | |
Hypertonicity | increases phosphorylation of | GSK3B | at S6 | in U373 | glycogen synthase kinase 3 beta | Perez-Pinera 2006 |
Hypertonicity | increases phosphorylation of | CRYAB | at S19,S45,S59 | in U373 MG | crystallin, alpha B | Ito 1997 |
Hypertonicity | increases phosphorylation of | PTK2B | in U-937 | protein tyrosine kinase 2 beta | Pandey 1999 | |
Hypertonicity | increases phosphorylation of | HIST2H3C | at S10 and S28 | in UL3 | histone cluster 2, H3c | Burkhart 2007 |
Hypertonicity | increases activity of | MAPK7 | in VSMC | mitogen-activated protein kinase 7 | Abe 1996 |
Subject | Verb Phrase (Action) | Object (Gene Symbol) | Phosphosite (if any) | Cell Type | Protein Description | Reference |
---|